
==== Front
Cell Death Differ
Cell Death Differ
Cell Death and Differentiation
1350-9047
1476-5403
Nature Publishing Group UK London

38649745
1297
10.1038/s41418-024-01297-3
Review Article
Cell death as an architect of adult skin stem cell niches
http://orcid.org/0000-0001-8402-9799
Lecomte Kim 12
http://orcid.org/0000-0001-6332-6225
Toniolo Annagiada 12
http://orcid.org/0000-0002-3181-431X
Hoste Esther esther.hoste@irc.vib-ugent.be

12
1 https://ror.org/04q4ydz28 grid.510970.a VIB Center for Inflammation Research, 9052 Ghent, Belgium
2 https://ror.org/00cv9y106 grid.5342.0 0000 0001 2069 7798 Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium
22 4 2024
22 4 2024
8 2024
31 8 957969
16 12 2023
9 4 2024
11 4 2024
© The Author(s) 2024, corrected publication 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Our skin provides a physical and immunological barrier against dehydration and environmental insults ranging from microbial attacks, toxins and UV irradiation to wounding. Proper functioning of the skin barrier largely depends on the interplay between keratinocytes- the epithelial cells of the skin- and immune cells. Two spatially distinct populations of keratinocyte stem cells (SCs) maintain the epidermal barrier function and the hair follicle. These SCs are inherently long-lived, but cell death can occur within their niches and impacts their functionality. The default cell death programme in skin is apoptosis, an orderly and non-inflammatory suicide programme. However, recent findings are shedding light on the significance of various modes of regulated necrotic cell death, which are lytic and can provoke inflammation within the local skin environment. While the presence of dying cells was generally regarded as a mere consequence of inflammation, findings in various human dermatological conditions and experimental mouse models of aberrant cell death control demonstrated that cell death programmes in keratinocytes (KCs) can drive skin inflammation and even tumour initiation. When cells die, they need to be removed by phagocytosis and KCs can function as non-professional phagocytes of apoptotic cells with important implications for their SC capacities. It is becoming apparent that in conditions of heightened SC activity, distinct cell death modalities differentially impact the different skin SC populations in their local niches. Here, we describe how regulated cell death modalities functionally affect epidermal SC niches along with their relevance to injury repair, inflammatory skin disorders and cancer.

Subject terms

Cell biology
Cell death and immune response
https://doi.org/10.13039/501100003130 Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 3G032320 3G032320 Lecomte Kim Hoste Esther https://doi.org/10.13039/501100005026 Stichting Tegen Kanker (Belgian Foundation Against Cancer) 365L04523 365L04523 Toniolo Annagiada Hoste Esther https://doi.org/10.13039/501100004385 Universiteit Gent (UGent) BOF24J/2023/138 Hoste Esther issue-copyright-statement© ADMC Associazione Differenziamento e Morte Cellulare 2024
==== Body
pmcFacts

Cell death is a central element in healthy mammalian skin and regulates hair cycling

Distinct types of regulated cell death differentially alter the various stem cell niches present in skin

Dysregulated cell death pathways in keratinocytes drive skin inflammation and carcinogenesis

Keratinocyte stem cells can act as occasional phagocytes by clearing dead/dying cells

Outstanding Questions

Which factors define the differential sensitivity of distinct skin stem cells to cell death?

Is there a role for non-apoptotic cell death programmes in hair cycling regulation?

Can we manipulate cell death responses to improve cutaneous wound healing, while preventing tumorigenesis?

What is the therapeutic potential of manipulating cell death switches in the skin?

The epidermis as a structural and immunological barrier

Skin comprises an epidermal layer, consisting of keratinocytes (KCs) and various immune cell-types including innate immune cells such as Langerhans cells and macrophages, but also adaptive memory T-cells and cells considered to bridge innate and adaptive immunity, namely γδ T-cells. Underneath the epidermal layer, the skin’s dermis is mainly populated by fibroblasts, adipocytes and endothelial cells [1]. KCs form the structure of the epidermis and its appendages, including hair follicles (HFs), sweat glands and sebaceous glands [2]. KCs located in the interfollicular epidermis maintain the permeability barrier of the skin, crucial to sustain the hydration levels of the body. This barrier is formed by differentiating KCs originating from the keratinocyte stem and progenitor cells, which are located in the basal layer -the lower layer of the epidermis where cells are attached to the basement membrane. Asymmetric SC divisions in this basal layer lead to the detachment of one of the daughter cells from this membrane, which results in the gradual differentiation of KCs to form a cornified layer protecting the skin from excessive water loss, UVB irradiation and pathogen entry [3]. This terminal differentiation process is also termed ‘cornification’ and is tightly orchestrated as reviewed elsewhere [4]. KCs, dermal fibroblasts and resident immune cells can release various cytokines, chemokines, danger-associated molecular patterns (DAMPs) and antimicrobial peptides to evoke an appropriate immune response upon skin challenge [1]. These molecules will bind their cognate receptors leading to the production of more inflammatory mediators and cytoprotective factors, thereby fighting off infections, while assisting in the maintenance of the skin barrier function. This intercellular crosstalk between KCs, fibroblasts and immune cells is crucial to mediate skin function, not only in homeostasis, but also in injury repair and other inflammatory conditions [1, 5].

Distinct skin stem cell niches exhibit different sensitivities to cell death

As a tissue with a remarkably high epithelial turnover rate, skin depends on a delicate balance between cell proliferation, differentiation, senescence and death. To provide for the specific proliferative needs of each epidermal compartment, mammalian skin contains different SC populations that are spatially separated in distinct niches [2]. These niches are not merely physical locations harbouring SCs, but refer to the microenvironment where intrinsic and extrinsic signals, including those emanating from dying/dead cells, converge to determine SC fates. Keratinocyte SCs residing in the basal layer of the interfollicular epidermis, termed epidermal stem cells (EpdSCs), proliferate to give rise to KCs that can differentiate into corneocytes and thereby maintain the barrier function of the skin [2]. Cell death is normally absent in the various layers of homeostatic interfollicular epidermis [6], indicating robust pro-survival mechanisms that facilitate the entry of KCs into the differentiation process and ensure successful completion of barrier formation (Fig. 1). Indeed, genetic mouse models have elucidated that aberrant cell death in the EpdSC niche often results in barrier perturbation and subsequent inflammation [7–10] (Table 1). A second population of keratinocyte SCs is located in the hair follicle (HF). These hair follicle stem cells (HFSCs) can be discriminated in mouse skin based on specific marker gene expression, such as Lgr5, Cd34 and Sox9 [11]. HFSCs also depend on their attachment to the basement membrane to maintain stemness, and undergo a specialized differentiation programme to ensure HF maintenance during the various stages of the hair cycle [12–14]. The spatially distinct niche where HFSCs reside is known as the bulge (Fig. 1). In contrast to the EpdSC niche, this tissue compartment experiences periodic bouts of substantial cell death during hair cycle regression (Box 1). In between EpdSCs and HFSCs, a region known as the junctional zone, LRIG1+ keratinocyte SCs are present and give rise to the murine sebaceous gland. A subpopulation of these SCs expresses GATA6, a marker for the sebaceous duct [15, 16]. The distinct populations of keratinocyte SCs are spatially and functionally separated in homeostatic skin conditions. However, during injury repair and in neoplastic conditions, several HFSCs are mobilized to regions where they normally do not reside to exert functions that differ from their homeostatic roles, a phenomenon that is termed SC plasticity [17–19].Fig. 1 Different SC populations in adult mouse skin and the major cell death programmes described in their niches.

The interfollicular epidermis of the skin consists of KCs, maintained by EpdSCs, and various immune cells. These SCs are attached to the basement membrane and give rise to transient amplifying cells capable to differentiate into corneocytes. In this epidermal niche, cell death is actively suppressed to ensure proper epidermal barrier formation, although recent findings describe the existence of specific NLRP10 inflammasome complexes, mediating pyroptotic cell death, in the differentiating epidermal layers [46]. HFs present in the skin are maintained by a specific population of SCs (HFSCs). In the HFSC niche, a substantial amount of KCs undergo periodic bouts of proliferation and subsequent apoptotic cell death. These apoptotic cells are phagocytosed by neighbouring basal KCs [23], ensuring absence of a significant immune response in this natural cycling process. Melanocyte stem cells (MeSCs) also populate the skin, and apoptosis of these cells has been linked to pigmentation disorders, such as vitiligo. SG sebaceous gland, DP dermal papilla.

Table 1 Summary of keratinocyte-selective knock-out mice with skin phenotypes steered by aberrant cell death control.

KC-specific KO	Skin phenotype	Targeted signalling pathway affecting cell death control	Refs	
A20 (Tnfaip3)	Dishevelled hair, sebocyte hyperplasia	TNF-mediated signalling	[72]	
Arts (Sept4)	Elevated number of HFSCs, accelerated wound healing	Apoptosis	[137]	
Atg7	Thickening of cornified layer	LC-3 dependent autophagy	[126, 127]	
Atg9a	Dermatitis, enhanced KC apoptosis	LC-3 independent autophagy	[128]	
Atg16L1	Thickening of cornified layer, more KC apoptosis, precocious hair cycling, accelerated wound healing	LC-3 dependent autophagy	[25]	
Bax in HFSCs (on Bak−/− backgound)	Increased HFSC compartment, accelerated wound healing	Intrinsic apoptosis	[60]	
Casp-8	Dermatitis, early postnatal lethality, KC necroptosis	Apoptosis, necroptosis, pyroptosis	[9, 10]	
Casp-9 in HFSCs	Accelerated wound repair, de novo HF regeneration	Intrinsic apoptosis	[139]	
cFLIP	Dermatitis, early postnatal lethality, KC apoptosis	Apoptosis, necroptosis	[66, 67]	
FADD	Dermatitis, early postnatal lethality, KC necroptosis	Extrinsic apoptosis	[8]	
Gpx4	Focal alopecia, dysmorphic hair, dermatitis	Ferroptosis	[32]	
Hmgb1	Accelerated wound healing, protection from tumour formation	NET formation in neutrophils	[132]	
Hoil-1	Dermatitis, early postnatal lethality	Apoptosis, necroptosis	[79]	
Hoip	Dermatitis, early postnatal lethality	Apoptosis, necroptosis	[79]	
Ikk1	Impaired epidermal barrier function, early postnatal lethality	TNF-mediated signalling	[71]	
Ikk2	Dermatitis, early postnatal lethality	TNF-mediated signalling	[65]	
Nemo	Dermatitis, enhanced TNF-dependent KC apoptosis, loss of pigmentation, early postnatal lethality	TNF-mediated signalling	[70]	
Nlrp10	Enhanced sensitivity to contact hypersensivity	Pyroptosis	[46]	
Otulin	Dermatitis, spontaneous tumour formation	Apoptosis, necroptosis	[78, 87]	
Rel-a and c-Rel	Dermatitis	TNF-mediated signalling	[68]	
Ripk1	Dermatitis, KC necroptosis and apoptosis	apoptosis, necroptosis	[7]	
Sharpin	Dermatitis, KC apoptosis	Apoptosis	[86]	
Tak1	Dermatitis, enhanced KC cell death	TNF-mediated signalling	[69]	
Traf2	Psoriasis-like dermatitis, enhanced KC cell death	TNF-mediated signalling	[73]	

Hair cycling is characterized by a growth phase of the HF (anagen), followed by a regression phase (catagen) mediated by excessive keratinocyte death, and a subsequent resting phase (telogen) [20] (Box 1). Growth of the HF is induced by reciprocal interactions between HFSCs and fibroblasts located in the dermal papilla, a specialized structure at the base of the HF [2, 21]. After growth, the length of the HF drastically reduces in the late stages of catagen, a process mediated by cell death and contraction of the dermal sheath, composed of smooth muscle cells wrapping the HF [20, 22]. Despite the extensive cell death that occurs in catagen, this physiological process is not accompanied by a pronounced inflammatory response. This implicates apoptosis, as a non-lytic cell death modality, as a major cell death programme in catagen [20]. Indeed, elegant intravital imaging studies demonstrated a spatial gradient of apoptotic basal KCs during the regression stage of the HF [23]. Signalling downstream of tumour necrosis factor-receptor-1 (TNFR1), a crucial decision point between pro-inflammatory signalling or cell death induction, has been implicated in hair cycling [24–26]. Not only is the death of KCs essential for regulating hair cycling, but apoptotic macrophages expressing TREM2 also influence HFSC proliferation (Box 1) [27]. Clearly, the distinct SC niches present in skin are confronted with varying rates of cell death, to which they respond differentially in order to maintain their specific tissue compartments.

Other SC populations present in the skin of most mammals include melanocyte stem cells (MeSCs) responsible for skin pigmentation, and sweat gland SCs [2, 28]. While limited information exists on the role of different cell death programmes in melanocyte and sweat gland biology, the death of melanocytes is associated with the common pigmentation disorder vitiligo. Moreover, genome-wide association studies (GWAS) have identified variations in genes involved in the executioner phase of apoptosis as susceptibility factors for vitiligo [29]. Here, we focus on examining the impact of cell death on keratinocyte SC niches in homeostasis and during injury repair and tumour formation, as recent advances highlight the crucial role played by various cell death programmes and their control mechanisms in preserving skin function in these conditions.

Box 1: Schematic representation of the different stages of the hair cycle

In mammalian skin, the coordinated death of keratinocytes is a central element in the regulation of HF regression. HFs cycle throughout life and can be in a state of active proliferation, termed anagen. During this stage, the HF protrudes deep into the dermis and facilitates hair growth. Induction of anagen depends on cell death responses in macrophages and keratinocytes present in the HFSC niche [23, 27]. Upon completion of anagen, a portion of keratinocyte SCs located in the HF die simultaneously in a cyclic manner. The regression stage of the HF is termed catagen and is facilitated by TNF-dependent apoptosis [24–26]. During catagen a large portion of HF cells are killed. However, a limited population of outer root sheet cells remain intact and migrate to the bulge to restrict HFSC activation [158]. Indeed, following regression, the HF enters a resting stage termed telogen during which HFSCs are quiescent.

Regulated cell death in the skin

Regulated cell death was long considered synonymous to apoptosis, but different types of molecularly controlled cell death pathways, including necroptosis, pyroptosis and ferroptosis, have now been described and implicated in the maintenance of skin immune homeostasis [7, 30–32]. Apoptosis is mediated by upstream initiator caspases (caspase-8 and -9), which activate downstream effector caspases (caspase-3, -6 and -7) responsible for executing the apoptotic process. This process is typically non-immunogenic due to the formation of apoptotic bodies that are phagocytosed by neighbouring cells [23]. Indeed, efficient removal of these cell corpses, a process termed efferocytosis, will prohibit the induction of a pronounced immune response [33]. Conversely, necroptosis and pyroptosis are lytic types of cell death that generate pores in the plasma membrane leading to the release of the intracellular content, including cytokines and DAMPs, in the extracellular environment. This induces a strong inflammatory response (Fig. 2) [34, 35]. Lytic cell death can potently drive skin inflammation, but upon certain challenges KCs can opt to undergo senescence, a cellular programme that is also capable of instigating inflammatory responses (Reviewed in [36]). The relative contribution of these two biological processes to dermatitis remains to be determined, but will likely depend on the nature of the inflammatory trigger.Fig. 2 Overview of the most prominent cell death modalities described in keratinocytes.

Apoptosis is the primary cell death modality in homeostatic keratinocytes. Intrinsic apoptosis is initiated by activation of the BCL-2 family members BAK and BAX, mediating mitochondrial leakage resulting in cytochrome c release into the cytosol. This event triggers formation of the apoptosome which assembles and activates caspase-9. Subsequently the executioner caspases-3 and -7 are cleaved and activated, mediating cell demise. Extrinsic apoptosis is triggered by binding of toxic agents to death receptors. This results in the assembly of a complex containing adaptor proteins (such as FADD and TRADD) and caspase-8, followed by cleavage of caspase-8 and subsequently of caspase-3 and -7. In conditions where apoptosis is blocked, binding of death receptors can lead to induction of necroptosis. This is mediated by RIPK3 phosphorylation leading to phosphorylation of MLKL, pore formation and cell lysis. Keratinocytes can die by pyroptosis through DAMP or PAMP recognition. Pyroptosis is preceeded by inflammasome formation. In this multi-protein complex, caspase-1 is assembled and cleaved, an event that leads to cleavage of pro-IL-1β and pro-IL-18 into their mature forms and cleavage of GSDMs, inducing pore formation in the plasma membrane and release of cytokines. Ferroptosis is a regulated cell death programme dependent on iron and resulting in lipid peroxidation of the phospholipids present in the plasma membrane by reactive oxygen species (ROS). GPX4 plays a crucial role in protecting cells from ferroptosis and this enzyme depends on cysteine as a co-factor.

Necroptosis is induced in conditions of deregulated apoptotic signalling, upon triggering of death receptors, type 1 interferon receptor, specific Toll-like receptors or infections with pathogens [37–41]. This type of programmed death relies on the activation of receptor interacting protein kinase 3 (RIPK3) and subsequent phosphorylation of mixed-lineage kinase domain-like protein (MLKL), resulting in MLKL translocation to the plasma membrane, subsequent pore formation and cell lysis [42]. Dysregulated apoptotic signalling can lead to sensitization of KCs to necroptosis and proper control of necroptosis in this cell-type is crucial to prevent dermatitis [7, 8]. Pyroptosis is another form of lytic cell death, usually caused by microbial infection, that relies on the proteolytic activation of gasdermin-D (GSDMD) by caspase-1 and caspase-11 or caspase-8, thereby unleashing GSDMD’s pore-forming activity [43]. Next to MLKL and GSDMD facilitating pore formation in different cell death types, plasma membrane rupture is further accomplished by NINJURIN-1 [44]. Activation of caspase-1 occurs in inflammasome complexes that are assembled after triggering of specific NOD-like receptors (NLRs), AIM2 (absent in melanoma 2) or pyrin. These receptors recognize various microbial insults or other stressors including extracellular ATP and uric acid crystals [45]. Cells dying by pyroptosis release bioactive IL-1β and IL-18, two cytokines that potently alter skin immunity. Increasing evidence suggests that inflammasome complexes play a crucial role in mediating skin immune surveillance [29, 30, 46]. Other forms of cell death have been described more recently in the context of cutaneous pathology, including ferroptosis, NETosis, autophagy-induced cell death, cuproptosis and panoptosis [47–49]. These cell death programmes will only be briefly discussed here, as their roles in skin homeostasis and inflammation are largely enigmatic.

Apoptosis and necroptosis

Apoptosis was the first type of cell death shown to be regulated by specific genetic programmes [50]. This cell death modality regulates important developmental processes and is crucial for tissue homeostasis [51, 52]. Although apoptotic cells can release compounds that affect tissue functioning [53], apoptosis is generally considered immune silent. However, an excessive amount of apoptosis can lead to secondary necrosis and subsequent inflammation [54, 55]. In homeostatic skin conditions, apoptotic caspases are not activated in the EpdSC niche [6]. Conversely, a marked abundance of apoptosis is induced in the HFSC niche during catagen, the regression stage of the hair cycle (Box 1). These cyclic bouts of cell death eliminate a substantial number of KCs and melanocytes in the HFSC niche, without provoking significant inflammation. This phenomenon thus offers a unique model for studying how tissue physiology is maintained in the presence of abundant cell death.

Apoptosis is induced by two different pathways, depending on the origin of the trigger (Fig. 2). The intrinsic pathway to apoptosis occurs upon dysregulation of intracellular homeostasis caused by toxic triggers or DNA damage, and involves BAX/BAK-induced mitochondrial pore formation and cytochrome c release from the mitochondria [56]. This induces the formation of the apoptosome and activation of caspase-9 [57]. In conditions of DNA damage triggering intrinsic apoptosis, the longevity of HFSCs is regulated by overexpression of the anti-apoptotic protein BCL-2 [58]. Upregulation of this protein in mouse KCs leads to abnormal HFSC niche architecture, evidenced by the enlarged bulge area that develops over time in these mice [59]. In agreement, depletion of the pro-apoptotic protein BAX in HFs results in HFSC niche expansion [60]. The extrinsic apoptotic pathway is triggered by cell death stimuli of the TNF superfamily, including TNF, Fas ligand (FASL) and TNF-related apoptosis-inducing ligand (TRAIL) that bind to their cognate receptors on the plasma membrane. Binding of TNF to TNFR1 results in the induction of a pro-inflammatory signalling cascade leading to nuclear factor-kappa B (NF-κB) activation and survival, or in the formation of a death-inducing complex. The decision between these paradoxical outcomes depends on the assembly of specific multi-protein complexes [61] (Fig. 3). Formation of complex I involves the recruitment of TRADD and RIPK1 to TNFR1, allowing the subsequent assembly of TRAF2/5, cIAP1/2 and the Linear Ubiquitination Chain Assembly Complex (LUBAC), activating a downstream signalling cascade leading to NF-κB and MAPK activation, induction of pro-inflammatory signalling and survival. The ubiquitin network associated with complex I is negatively regulated by A20, CYLD and OTULIN, which destabilize the signalling complex and attenuate signalling to MAPKs and NF-κB [61]. In a pro-survival context, caspase-8 can cleave RIPK1 thereby limiting apoptotic and necroptotic cell death [62]. However, TNF can also induce cell death via the assembly of a secondary cytosolic complex, termed complex II, which originates from the binding of FAS-associated death domain-containing protein (FADD) to the receptor-dissociated complex I components TRADD and/or RIPK1. This complex now functions as a platform for binding and activation of caspase-8 triggering apoptotic or pyroptotic cell death, depending on the cellular context [63, 64]. In the absence of caspase-8 activation, a different complex termed the necrosome can be assembled, involving RIPK1 and RIPK3, which drives necroptosis. The significance of precisely controlling the formation of TNF-induced complexes in KCs is evident from the severe inflammatory skin phenotypes that arise after depletion of the proteins constituting these complexes or the checkpoints regulating their activity in mouse KCs [65–73] (Table 1). Additionally, several human skin pathologies are associated with variations in genes responsible for assembling TNF-induced complexes [74].Fig. 3 Schematic overview of TNFR-mediated signalling.

Binding of TNF to TNFR1 results in the downstream formation of multi-protein complexes that mediate either survival, apoptosis or necroptotic cell death. Formation of complex I at the plasma membrane results in activation of NF-kB signalling and transcription of pro-inflammatory and pro-survival genes. In conditions where complex I is disassembled, a subsequent complex II is formed, resulting in apoptosis. When caspase-8 is absent or inhibited, the necrosome complex is assembled, leading to phosphorylation of RIPK3, followed by phosphorylation of MLKL and pore formation in the plasma membrane.

Genetic ablation of key apoptotic mediators, such as caspase-8, FADD and RIPK1, in mouse KCs triggers KC necroptosis and severe skin inflammation [7–10] (Table 1). The induction of necroptosis in KCs initiates a feed forward cycle of inflammation, subsequent epidermal barrier permeability and skin demise, explaining the perinatal or early postnatal lethality associated with these genotypes. Mice lacking caspase-8 selectively in KCs exhibit hyperplasia of the basal and spinous layers, expression of keratin-6 (K6) in the interfollicular epidermis, enhanced cell death rates in the epidermis and marked infiltration of specific subsets of immune cells in both epidermis and dermis [9, 10]. The epidermis of skin with FADD-deficient KCs shows similar defects [8]. Likewise, mice lacking RIPK1 in KCs exhibit epidermal thickening, reduced K10 expression and abundant presence of apoptotic and necroptotic cells in their epidermis. Ablation of RIPK3 in these KC-selective RIPK1-deficient mice averts skin inflammation, indicating the high potency of necroptosis in driving dermatitis [7]. RIPK1 prevents KC necroptosis in a kinase-independent manner by binding to RIPK3 via RIP homotypic interaction motif (RHIM) domains. Absence of the RIPK1 RHIM domain in KCs leads to spontaneous Z-DNA-binding protein 1 (ZBP1)-dependent necroptosis, severe skin inflammation and perinatal lethality. Indeed, RIPK1 RHIM is essential to prevent ZBP1 from binding and activating RIPK3 and subsequent MLKL phosporylation [75–77]. Interestingly, when mice with these highly inflamed skin phenotypes due to absence of apoptotic genes are born, inflammation seems to be increased from postnatal day 5 onwards, coinciding with the initiation of the first round of anagen [8, 78, 79]. It is therefore tempting to speculate that the altered activation state of the HFSCs contributes to the inflammatory phenotypes observed in these mice.

Whether KCs die by apoptosis or necroptosis has pivotal implications for skin function. Whitin the TNFR-pathway, various key decision points that switch the cell death programme from apoptosis to necroptosis have been identified [61] (Fig. 3). One of these control mechanisms is ubiquitination, a post-translational modification in which chains of ubiquitin (Ubq) molecules are attached on substrates. This process is mediated by ubiquitin E3 ligases and reversed by deubiquitinases (DUBs) [80]. These Ubq chains are linked by lysine residues present in Ubq or by its N-terminal methionine residue (therefore also termed M1 chains) and have important scaffolding functions for the assembly of the pro-inflammatory complex 1 upon TNF triggering [81]. Linear Ubq chains are attached to their substrates by the E3 ligase complex LUBAC consisting of HOIL-1 (heme-oxidized IRP2 ubiquitin ligase 1), HOIP (HOIL-1 interacting protein) and SHARPIN (Shank-associated RH-domain interacting protein), and are removed by the DUBs CYLD (cylindromatosis) and OTULIN (OTU deubiquitinase with linear linkage specificity) [82–84]. While CYLD can remove both K63 and M1 Ubq chains, OTULIN has exclusive affinity for M1 Ubq chains [83, 85]. Interestingly, genetic deletion of single LUBAC components or of the DUBs that can remove M1 chains, selectively in KCs, results in severe inflammatory skin phenotypes caused by excessive KC death [78, 79, 86, 87] (Table 1). While deletion of HOIP and HOIL-1 in KCs results in massive skin inflammation and early postnatal lethality, which is delayed upon compound removal of TNF or TNFR1 [79], the phenotypes of mice lacking functional SHARPIN or keratinocyte-selective OTULIN are respectively milder or fully rescued upon removal of TNFR1 [78, 84, 87, 88], indicating that different molecular mechanisms regulate KC lethality in these distinct genetic contexts. Importantly, patients carrying loss-of-function mutations in the OTULIN gene suffer from ORAS (OTULIN-related autoinflammatory syndrome), a severe and often lethal autoinflammatory syndrome affecting multiple organs including skin. ORAS patients present with skin lesions reminiscent of nodular panniculitis with neutrophil infiltration and apoptotic cells are evident in these lesions [82, 89]. They are successfully treated with anti-TNF therapy [82], further emphasizing that proper control of TNFR-mediated signalling is critical for skin immunosurveillance. It is worth noting that keratinocyte SC niches are highly sensitive to TNF-mediated cell death in OTULIN-deficient conditions, causing autoinflammation and even carcinogenesis due to enhanced apoptotic and necroptotic responses in KCs [78, 87]. This is not the case in other high-turnover SC niches, such as the intestinal epithelium, where OTULIN deficiency does not cause spontaneous pathology [90].

Presence of apoptotic and necroptotic cells has been observed in patients suffering from a range of inflammatory skin diseases, including psoriasis, atopic dermatitis, vitiligo and epidermolysis bullosa [31, 91, 92]. In addition, genetic linkage studies have implicated apoptotic and necroptotic signalling pathways in various dermatological conditions. GWAS identified genetic variations in TNFAIP3 (encoding A20), TNIP1 and FASL, involved in apoptotic and necroptotic cell death regulation, as susceptibility factors for psoriasis vulgaris [93, 94]. In alopecia areata, a common hair loss disorder associated with autoinflammation, polymorphisms in the anti-apoptotic gene BCL2L2 have been identified [95]. Most importantly, TNF-neutralizing antibodies are highly successful for clinical treatment of moderate to severe psoriasis [96]. Skin samples from psoriatic patients show elevated levels of several necroptosis-associated proteins, such as RIPK1, RIPK3 and MLKL, and recent findings demonstrated that inhibiting KC necroptosis significantly delays the development of imiquimod-induced psoriasis in mice [91, 97]. Due to the fact that cell death and inflammation are so tightly linked, with cell death being a potential instigator or consequence of inflammation and vice versa, additional studies are needed to reveal which cell death mediators play a causative role in dermatitis. The first oral, selective RIPK1 inhibitor GSK2982772 is currently being tested for treatment of active plaque psoriasis patients, leading to reduced epidermal thickness and lower inflammatory infiltrates [98].

Pyroptosis

Pyroptosis is an inflammatory lytic cell death programme, characterized by rupture of the cell membrane due to gasdermin-mediated pore formation. Originally described as candidate genes causing hair loss [99], the mouse GSDM superfamily includes Gsdma (comprising 3 homologues), -c (comprising 4 homologues), -d and -e, while the human genome encodes for GSDM-A to -E and pejvakin. These proteins require cleavage to translocate and insert into the cell membrane [100–102]. While pyroptosis was initially believed to be a cell death programme exclusive to innate immunity cells like monocytes and macrophages, a surge in genetic evidence now suggests a crucial role for pyroptosis in KC and melanocyte biology [45]. Loss-of-function mutations in the human NLRP1 (Nod-like receptor family pyrin domain containing 1) gene, a pyroptotic receptor, are the causative factor for vitiligo-associated multiple autoimmune disease. These patients typically suffer from generalized vitiligo often associated with psoriasis or systemic lupus erythematosus [30]. Moreover, gain-of-function (GOF) mutations in NLRP1 have been identified in patients with dermatological conditions as a result of spontaneous inflammasome activation in KCs [103–105]. The importance of proper control of NLRP1 activity in skin is also apparent in patients carrying hypomorphic or knockout alleles of the NLRP1 inhibitor DPP9 (dipeptidyl peptidase 9), who present with skin pigmentation abnormalities [106]. Patients suffering from Cryopyrin-associated periodic syndrome (CAPS), due to GOF mutations in the inflammasome receptor NLRP3, present with severe cutaneous rashes [107]. Knockin of one such Nlrp3 mutation in mice phenocopies human CAPS, including severe dermatitis [108, 109]. It is important to stipulate that dysregulated inflammasome signalling can drive altered secretion of IL-1 and IL-18 by various cell-types and is not necessarily linked to enhanced cell death levels in KC compartments. However, mice carrying GOF mutations in mouse Nlrp3 are protected from dermatitis when crossed onto a GSDMD-deficient background, implicating a pivotal role for GSDMD-mediated pyroptosis in the skin [110]. Also, GSDME-mediated pyroptosis has been shown to protect keratinocytes from UV-radiation and viral infections [111, 112]. A third inflammasome receptor for which genetic variations have been linked to dermatological conditions is PYRIN (encoded by MEFV). These mutations recapitulate an immune response triggered by pathogens in skin and patients present with neutrophilic dermatosis, which can be ameliorated by blocking IL-1 signalling [113].

Whole-genome studies in psoriatic patients revealed SNPs (Single Nucleotide Polymorphisms) in AIM2, an activator of pyroptosis [114]. Intriguingly, AIM2 is crucial in establishing inflammatory memory in mouse EpdSCs, enabling them to respond more efficiently to subsequent insults [115]. KCs also express high levels of NLRP10 in the EpdSC niche upon differentiation, driving inflammasome formation in conditions of mitochondrial damage [46]. The role of this inflammasome in mediating cutaneous immunity is also apparent from the enhanced sensitivity of mice with keratinocyte-selective deletion of Nlrp10 to contact dermatitis [116]. Drugs targeting inflammasome activation or outcome, such as colchicine and Anakinra, are used to treat several inflammatory skin diseases, including neutrophilic dermatoses and hidradenitis suppurativa [117, 118]. Various clinical trials targeting IL-1 family cytokines to ameliorate dermatological conditions have been initiated and are reviewed elsewhere [119].

Ferroptosis

Ferroptosis is a cell death pathway that critically depends on iron radicals and peroxidation of plasma membrane lipids [120, 121]. Cells undergoing ferroptosis display shrinkage of their mitochondria with an increase in their membrane density and cristae reduction, but no cell shrinkage or swelling as seen in respectively apoptotic or necroptotic cells [121, 122]. Genetic deletion of Gpx4 (glutathione peroxidase 4), the main enzyme protecting cells from ferroptosis [120, 123], in KCs induces dysmorphic HFs, focal alopecia and dermatitis in mice. However, these phenotypes are transient in nature and mice lacking GPX4 in KCs have a normal lifespan [124]. So far, there is no in vivo proof directly linking ferroptotic cell death to inflammatory skin conditions. However, downregulation of GPX4 has been demonstrated in lesional skin of psoriatic patients, and treatment with the ferroptosis inhibitor ferrostatin-1 was shown to alleviate psoriasiform inflammation in mice [48]. Whether ferroptotic cell death is a cause or consequence of inflammation in these psoriatic plaques remains to be investigated.

Autophagy

Macro-autophagy (hereafter referred to as autophagy) is the major cellular machinery for the recycling of amino acids. While this programme serves as an important pro-survival mechanism, autophagy can also lead to cell death. Constitutive ablation of genes essential for autophagy results in embryonically lethal phenotypes, indicating the crucial role of this process in tissue development (reviewed in [125]). Impairment of key autophagy genes in KCs demonstrated a crucial role for this process in the terminal differentiation programme that is initiated in the EpdSC niche. Indeed, KC-selective ATG (autophagy-related gene) 7 or ATG16L1-deficient mice exhibit enhanced sensitivity to DNA damage, altered lipid composition and a thickened cornified layer, pointing to defects in the desquamation programme [25, 126, 127] (Table 1). A defective autophagic flux resulting from depletion of ATG16L1 in KCs, leads to precocious anagen induction due to enhanced cell death rates, indicating that the apoptotic death of KCs impacts on the activation kinetics of HFSCs [25]. Also ATG9A has recently been identified as a critical autophagy mediator for maintaining skin homeostasis. Removal of this factor from KCs results in substantial epidermal cell death and spontaneous dermatitis due to improper TNF detoxification, identifying a novel control mechanism preserving skin integrity [128].

Polymorphisms in human ATG16L1 have been linked to the dermatological conditions psoriasis vulgaris and palmoplantar pustulosis, further suggesting a role for keratinocyte autophagy in skin immunity [129, 130]. GWAS analyses of alopecia areata patients demonstrated associations with genes involved in autophagy, such as STX17 (Syntaxin 17) [95]. Together, these observations demonstrate that autophagy plays important roles in KCs, protecting them from TNF toxicity and safeguarding the molecular clock that regulates HFSC proliferation.

The impact of cell death on skin regeneration

Epithelial tissue repair depends on the activation of tissue-resident SCs [131]. Cell death responses are crucial in orchestrating the highly complex process of regeneration, eliminating immune cells recruited to the wound site and counterbalancing the accelerated epithelial proliferative state. Recent findings shed light on how cell death shapes the activation of SCs during regeneration. When skin is wounded, the epidermal barrier is breached and cytokines, chemokines and danger-associated molecular patterns (DAMPs) are released, inducing an immune response that assists in injury repair [5]. The first immune cells that infiltrate wounded skin in large numbers are neutrophils that are recruited by KCs secreting HMGB1 (high mobility group box-1), a prototypical DAMP [132]. These neutrophils can execute a specific cell death pathway involving the production of neutrophil extracellular traps (NETs), a process that is highly prominent in diabetic wounds. NETs serve as a bacterial defence mechanism, but are detrimental to cutaneous injury repair [47, 133]. Genetic and pharmacologic targeting of HMGB1 in mouse KCs suppresses NET formation and accelerates wound closure in normoglycemic and diabetic skin [132, 134]. Besides neutrophils, macrophages and dendritic cells infiltrate injured skin and contribute to healing not only by promoting inflammation, but also by acting as phagocytes removing dead cells through efferocytosis. These macrophages die by apoptosis during the skin repair process, hence, preventing apoptotic responses in this cell lineage significantly delays injury repair [135] (Fig. 4).Fig. 4 Role of different cell death modalities in cutaneous injury repair.

Cell death is an inherent part of regenerative skin responses. After clot formation an inflammatory response mediates the infiltration of immune cells into the skin. Crosstalk between KCs and immune cells is crucial in recruiting a range of innate immune cells to the wound site. These cells signal to KCs to proliferate and migrate into the granulation tissue. When re-epithelialisation is finalized, skin-infiltrated immune cells including macrophages and dendritic cells play a dual role in the resolution of inflammation due to their phagocytotic capacities and production of anti-inflammatory cytokines. Alongside cell death by apoptosis, other forms of regulated cell death, such as NETosis, impact wound healing dynamics of the skin.

Activities of the effector caspases-3 and -7 are crucial for skin regeneration due to their capacities to eliminate damaged cells and release proliferative signals [136]. However, mice deficient for the pro-apoptotic protein ARTS exhibit accelerated cutaneous wound repair [137]. While apoptosis is paramount for skin regeneration, it is clear that proper control of apoptotic cell death rates determines the healing kinetics. This is also exemplified in a mouse model in which the crucial cell death regulator cFLIP can no longer be cleaved by caspase-8, resulting in exaggerated cell death and a significant delay in skin regeneration [138]. Not only do extrinsic apoptotic pathways mediate skin regeneration, but the deregulation of intrinsic apoptotic signalling in HFSCs can accelerate cutaneous wound responses [139]. Future research on other regulated cell death modalities and the mechanisms that keep them in check during tissue regeneration holds promise for novel therapeutic approaches in management of wound care.

Proper efferocytosis by macrophages and dendritic cells present in wounded skin is crucial for injury repair due to its anti-inflammatory effects [33, 140] (Fig. 4). Inhibition of efferocytosis receptors, such as AXL and TIMD4, delay the healing kinetics of murine wounds and upregulation of pathways mediating cell clearance has been shown in cutaneous mouse wounds and human diabetic wounds [141]. When apoptotic cell death rates surpass the phagocytic capacity of cells present in the microenvironment, secondary necrosis resulting in lytic cell death can occur [142]. While the mechanisms mediating efferocytosis have mainly been described in professional phagocytes, a role for KCs and fibroblasts as occasional phagocytes in skin is emerging. Indeed, phagocytosis of dying/dead cells by basal KCs of the HF has been described during the catagen stage of hair cycling and recent findings show that efferocytosis by HFSCs impacts their regenerative capacities [23, 143].

Cell death and skin tumour formation

While cytotoxic cancer therapies aim to kill tumour cells, cell death responses can induce proliferation of neighbouring stem cells [144] and even stimulate the repopulation of tumours undergoing radiotherapy [145]. In melanoma, cancer cells that escape apoptosis gain migratory and metastatic capacities [146]. So, while cell death is a crucial tumour-suppressive mechanism by removing (pre)malignant cells, it can also promote tumorigenesis by stimulating inflammatory, regenerative and even metastatic responses. Skin cancers also adhere to this duality. Overexpression of the anti-apoptotic protein BCL-XL sensitizes mouse KCs to carcinogenesis and malignancy [147]. Genetic alterations in KC survival pathways, for example those resulting in constitutive activation of AKT, accelerate skin tumour formation [148]. In carcinogenic conditions, TNF-mediated signalling pathways are crucial in determining the propensity of KCs to either proliferate or die. Mice deficient for both TNF receptors are resistant to chemically-induced skin cancer protocols [149]. Along these lines, NF-κB blockade by overexpression of the NFκB-inhibitor IκBα in human KCs promotes their transformation to squamous cell carcinomas (SCCs) and in mice, these conditions result in increased KC apoptosis and spontaneous SCC formation [150, 151]. A recent genetic screen identified several hits in the TNF signalling cascade sensitizing melanoma cells to elimination by T-cells, demonstrating the potential of manipulating cell death pathways in immune checkpoint blockade [152].

As is the case for apoptosis, necroptosis and pyroptosis can have either tumour-promoting or -suppressing effects in the skin, depending on the tumour type and stage. In various tumour types including malignant melanoma, necroptotic mediators are strongly suppressed, indicating acquired necroptotic resistance of tumour cells [153]. In line with this, senescent melanocytes that are capable of resisting cell death, are emerging as a potential cell-of-origin in melanoma and specific targeting of factors released by senescent melanocytes are showing promise in counteracting melanoma [154, 155]. In keratinocyte-derived tumours, such as head and neck SCC, a substantial amount of necroptosis has been reported and high levels of phosphorylated MLKL were shown to correlate with lymph node metastasis and tumour progression [156]. Intriguingly, naked mole-rats- a species known for its remarkable resistance to skin carcinogenesis- lack the necroptotic mediator RIPK3, suggesting a putative role for necroptosis in neoplastic skin responses [157]. This study also demonstrates that pharmacological or genetic inhibition of necroptosis delays chemically-induced skin carcinogenesis in mice [157]. However, more research is needed to elucidate whether, when and how specific cell death programmes should be targeted to enable more efficient and safer removal of tumour cells.

Conclusions

Collectively, the tight balance between keratinocyte proliferation and removal is crucial for the skin’s barrier function, but also for proper cycling of HFs. While periodic bouts of cell death are inherent to the HFSC niche, the abundant presence of dying cells in the EpdSC niche is detrimental to proper epidermal barrier function. While there is no doubt that apoptosis represents a crucial cell death modality important for skin homeostasis, hair cycling, and for counterbalancing tumour formation, a growing body of evidence points to important contributions of other regulated cell death programmes in these processes. The consequences of distinct cell death programmes on the survivor cells within specific SC niches are beginning to unravel as our understanding of the molecular executioners of these programmes increases. This allows us to pinpoint more precisely which types of cell death occur in the different SC compartments of the skin. However, our understanding of why certain progenitor cells are more sensitive to specific types of cell death has only recently begun to unfold. It remains unclear how this sensitivity is regulated and potentially altered in disease. Understanding these complex concepts holds the key to revealing the therapeutic potential of manipulating cell death programmes within the appropriate tissue context, thereby advancing clinical treatments of skin diseases.

Acknowledgements

We apologize to the authors whose work we could not discuss due to space limitations. We thank Geert van Loo for critical reading of the manuscript. KL is supported by an FWO research project (3G032320), AT is supported by a ‘Stichting tegen Kanker’ research project (365L04523). Work in the lab of EH is funded by a Leo Foundation Award Region EMEA, the Special Research Fund of Ghent University (BOF/24J/2023/138) and FWO (Research grant 3G032320). Figures were created using Inkscape and Biorender.

Author contributions

KL wrote the manuscript and designed figures. AT wrote the manuscript and designed figures. EH conceptualized, wrote and revised the manuscript.

Competing interests

The authors declare no competing interests.

The original online version of this article was revised: The authors Kim Lecomte and Annagiada Toniolo have contributed equally to this work. Although Kim Lecomte and Annagiada Toniolo were indicated as co-first authors.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Kim Lecomte, Annagiada Toniolo.

Change history

9/2/2024

A Correction to this paper has been published: 10.1038/s41418-024-01362-x
==== Refs
References

1. Swamy M Jamora C Havran W Hayday A Epithelial decision makers: in search of the ‘epimmunome’ Nat Immunol 2010 11 656 65 10.1038/ni.1905 20644571
Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of the ‘epimmunome’. Nat Immunol. 2010;11:656–65. 10.1038/ni.190520644571 10.1038/ni.1905
2. Hsu YC, Fuchs, E. Building and maintaining the skin. Cold Spring Harb Perspect Biol. 2022;14. 10.1101/cshperspect.a040840
3. Lechler T Fuchs E Asymmetric cell divisions promote stratification and differentiation of mammalian skin Nature 2005 437 275 80 10.1038/nature03922 16094321
Lechler T, Fuchs E. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature. 2005;437:275–80. 10.1038/nature0392216094321 10.1038/nature03922
4. Candi E Schmidt R Melino G The cornified envelope: a model of cell death in the skin Nat Rev Mol Cell Biol 2005 6 328 40 10.1038/nrm1619 15803139
Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol. 2005;6:328–40. 10.1038/nrm161915803139 10.1038/nrm1619
5. Naik S Larsen SB Cowley CJ Fuchs E Two to tango: dialog between immunity and stem cells in health and disease Cell 2018 175 908 20 10.1016/j.cell.2018.08.071 30388451
Naik S, Larsen SB, Cowley CJ, Fuchs E. Two to tango: dialog between immunity and stem cells in health and disease. Cell. 2018;175:908–20. 10.1016/j.cell.2018.08.07130388451 10.1016/j.cell.2018.08.071
6. Lippens S Kockx M Knaapen M Mortier L Polakowska R Verheyen A Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing Cell Death Differ 2000 7 1218 24 10.1038/sj.cdd.4400785 11175259
Lippens S, Kockx M, Knaapen M, Mortier L, Polakowska R, Verheyen A, et al. Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ. 2000;7:1218–24. 10.1038/sj.cdd.440078511175259 10.1038/sj.cdd.4400785
7. Dannappel M Vlantis K Kumari S Polykratis A Kim C Wachsmuth L RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis Nature 2014 513 90 94 10.1038/nature13608 25132550
Dannappel M, Vlantis K, Kumari S, Polykratis A, Kim C, Wachsmuth L, et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature. 2014;513:90–94. 10.1038/nature1360825132550 10.1038/nature13608
8. Bonnet MC Preukschat D Welz PS van Loo G Ermolaeva MA Bloch W The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation Immunity 2011 35 572 82 10.1016/j.immuni.2011.08.014 22000287
Bonnet MC, Preukschat D, Welz PS, van Loo G, Ermolaeva MA, Bloch W, et al. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity. 2011;35:572–82. 10.1016/j.immuni.2011.08.01422000287 10.1016/j.immuni.2011.08.014
9. Kovalenko A Kim JC Kang TB Rajput A Bogdanov K Dittrich-Breiholz O Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease J Exp Med 2009 206 2161 77 10.1084/jem.20090616 19720838
Kovalenko A, Kim JC, Kang TB, Rajput A, Bogdanov K, Dittrich-Breiholz O, et al. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J Exp Med. 2009;206:2161–77. 10.1084/jem.2009061619720838 10.1084/jem.20090616
10. Lee P Lee DJ Chan C Chen SW Ch’en I Jamora C Dynamic expression of epidermal caspase 8 simulates a wound healing response Nature 2009 458 519 23 10.1038/nature07687 19204729
Lee P, Lee DJ, Chan C, Chen SW, Ch’en I, Jamora C. Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature. 2009;458:519–23. 10.1038/nature0768719204729 10.1038/nature07687
11. Joost S Annusver K Jacob T Sun X Dalessandri T Sivan U The molecular anatomy of mouse skin during hair growth and rest Cell Stem Cell 2020 26 441 57 e447 10.1016/j.stem.2020.01.012 32109378
Joost S, Annusver K, Jacob T, Sun X, Dalessandri T, Sivan U, et al. The molecular anatomy of mouse skin during hair growth and rest. Cell Stem Cell. 2020;26:441–57 e447. 10.1016/j.stem.2020.01.01232109378 10.1016/j.stem.2020.01.012
12. Cotsarelis G Sun TT Lavker RM Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis Cell 1990 61 1329 37 10.1016/0092-8674(90)90696-c 2364430
Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 1990;61:1329–37. 10.1016/0092-8674(90)90696-c2364430 10.1016/0092-8674(90)90696-c
13. Blanpain C Lowry WE Geoghegan A Polak L Fuchs E Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche Cell 2004 118 635 48 10.1016/j.cell.2004.08.012 15339667
Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004;118:635–48. 10.1016/j.cell.2004.08.01215339667 10.1016/j.cell.2004.08.012
14. Greco V Chen T Rendl M Schober M Pasolli HA Stokes N A two-step mechanism for stem cell activation during hair regeneration Cell Stem Cell 2009 4 155 69 10.1016/j.stem.2008.12.009 19200804
Greco V, Chen T, Rendl M, Schober M, Pasolli HA, Stokes N, et al. A two-step mechanism for stem cell activation during hair regeneration. Cell Stem Cell. 2009;4:155–69. 10.1016/j.stem.2008.12.00919200804 10.1016/j.stem.2008.12.009
15. Donati G Rognoni E Hiratsuka T Liakath-Ali K Hoste E Kar G Wounding induces dedifferentiation of epidermal Gata6(+) cells and acquisition of stem cell properties Nat Cell Biol 2017 19 603 13 10.1038/ncb3532 28504705
Donati G, Rognoni E, Hiratsuka T, Liakath-Ali K, Hoste E, Kar G, et al. Wounding induces dedifferentiation of epidermal Gata6(+) cells and acquisition of stem cell properties. Nat Cell Biol. 2017;19:603–13. 10.1038/ncb353228504705 10.1038/ncb3532
16. Jensen KB Collins CA Nascimento E Tan DW Frye M Itami S Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis Cell Stem Cell 2009 4 427 39 10.1016/j.stem.2009.04.014 19427292
Jensen KB, Collins CA, Nascimento E, Tan DW, Frye M, Itami S, et al. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell. 2009;4:427–39. 10.1016/j.stem.2009.04.01419427292 10.1016/j.stem.2009.04.014
17. Donati G Watt FM Stem cell heterogeneity and plasticity in epithelia Cell Stem Cell 2015 16 465 76 10.1016/j.stem.2015.04.014 25957902
Donati G, Watt FM. Stem cell heterogeneity and plasticity in epithelia. Cell Stem Cell. 2015;16:465–76. 10.1016/j.stem.2015.04.01425957902 10.1016/j.stem.2015.04.014
18. Ge Y Fuchs E Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer Nat Rev Genet 2018 19 311 25 10.1038/nrg.2018.9 29479084
Ge Y, Fuchs E. Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer. Nat Rev Genet. 2018;19:311–25. 10.1038/nrg.2018.929479084 10.1038/nrg.2018.9
19. Sun, X, Joost, S, Kasper, M. Plasticity of epithelial cells during skin wound healing. Cold Spring Harb Perspect Biol. 2023;15. 10.1101/cshperspect.a041232
20. Muller-Rover S Handjiski B van der Veen C Eichmuller S Foitzik K McKay IA A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages J Invest Dermatol 2001 117 3 15 10.1046/j.0022-202x.2001.01377.x 11442744
Muller-Rover S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay IA, et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol. 2001;117:3–15. 10.1046/j.0022-202x.2001.01377.x11442744 10.1046/j.0022-202x.2001.01377.x
21. Jahoda CA Horne KA Oliver RF Induction of hair growth by implantation of cultured dermal papilla cells Nature 1984 311 560 2 10.1038/311560a0 6482967
Jahoda CA, Horne KA, Oliver RF. Induction of hair growth by implantation of cultured dermal papilla cells. Nature. 1984;311:560–2. 10.1038/311560a06482967 10.1038/311560a0
22. Heitman N Sennett R Mok KW Saxena N Srivastava D Martino P Dermal sheath contraction powers stem cell niche relocation during hair cycle regression Science 2020 367 161 6 10.1126/science.aax9131 31857493
Heitman N, Sennett R, Mok KW, Saxena N, Srivastava D, Martino P, et al. Dermal sheath contraction powers stem cell niche relocation during hair cycle regression. Science. 2020;367:161–6. 10.1126/science.aax913131857493 10.1126/science.aax9131
23. Mesa KR Rompolas P Zito G Myung P Sun TY Brown S Niche-induced cell death and epithelial phagocytosis regulate hair follicle stem cell pool Nature 2015 522 94 97 10.1038/nature14306 25849774
Mesa KR, Rompolas P, Zito G, Myung P, Sun TY, Brown S, et al. Niche-induced cell death and epithelial phagocytosis regulate hair follicle stem cell pool. Nature. 2015;522:94–97. 10.1038/nature1430625849774 10.1038/nature14306
24. Tong X Coulombe PA Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion Genes Dev 2006 20 1353 64 10.1101/gad.1387406 16702408
Tong X, Coulombe PA. Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev. 2006;20:1353–64. 10.1101/gad.138740616702408 10.1101/gad.1387406
25. Van Hove L Toniolo A Ghiasloo M Lecomte K Boone F Ciers M Autophagy critically controls skin inflammation and apoptosis-induced stem cell activation Autophagy 2023 19 2958 71 10.1080/15548627.2023.2247742 37615626
Van Hove L, Toniolo A, Ghiasloo M, Lecomte K, Boone F, Ciers M, et al. Autophagy critically controls skin inflammation and apoptosis-induced stem cell activation. Autophagy. 2023;19:2958–71. 10.1080/15548627.2023.224774237615626 10.1080/15548627.2023.2247742
26. Xie Y Chen D Jiang K Song L Qian N Du Y Hair shaft miniaturization causes stem cell depletion through mechanosensory signals mediated by a Piezo1-calcium-TNF-alpha axis Cell Stem Cell 2022 29 70 85 e76 10.1016/j.stem.2021.09.009 34624205
Xie Y, Chen D, Jiang K, Song L, Qian N, Du Y, et al. Hair shaft miniaturization causes stem cell depletion through mechanosensory signals mediated by a Piezo1-calcium-TNF-alpha axis. Cell Stem Cell. 2022;29:70–85 e76. 10.1016/j.stem.2021.09.00934624205 10.1016/j.stem.2021.09.009
27. Castellana D Paus R Perez-Moreno M Macrophages contribute to the cyclic activation of adult hair follicle stem cells PLoS Biol 2014 12 e1002002 10.1371/journal.pbio.1002002 25536657
Castellana D, Paus R, Perez-Moreno M. Macrophages contribute to the cyclic activation of adult hair follicle stem cells. PLoS Biol. 2014;12:e1002002 10.1371/journal.pbio.100200225536657 10.1371/journal.pbio.1002002
28. Lu CP Polak L Rocha AS Pasolli HA Chen SC Sharma N Identification of stem cell populations in sweat glands and ducts reveals roles in homeostasis and wound repair Cell 2012 150 136 50 10.1016/j.cell.2012.04.045 22770217
Lu CP, Polak L, Rocha AS, Pasolli HA, Chen SC, Sharma N, et al. Identification of stem cell populations in sweat glands and ducts reveals roles in homeostasis and wound repair. Cell. 2012;150:136–50. 10.1016/j.cell.2012.04.04522770217 10.1016/j.cell.2012.04.045
29. Jin Y Birlea SA Fain PR Ferrara TM Ben S Riccardi SL Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo Nat Genet 2012 44 676 80 10.1038/ng.2272 22561518
Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, et al. Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet. 2012;44:676–80. 10.1038/ng.227222561518 10.1038/ng.2272
30. Jin Y Mailloux CM Gowan K Riccardi SL LaBerge G Bennett DC NALP1 in vitiligo-associated multiple autoimmune disease N Engl J Med 2007 356 1216 25 10.1056/NEJMoa061592 17377159
Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007;356:1216–25. 10.1056/NEJMoa06159217377159 10.1056/NEJMoa061592
31. Lippens S Hoste E Vandenabeele P Agostinis P Declercq W Cell death in the skin Apoptosis 2009 14 549 69 10.1007/s10495-009-0324-z 19221876
Lippens S, Hoste E, Vandenabeele P, Agostinis P, Declercq W. Cell death in the skin. Apoptosis. 2009;14:549–69. 10.1007/s10495-009-0324-z19221876 10.1007/s10495-009-0324-z
32. Sengupta A Lichti UF Carlson BA Ryscavage AO Gladyshev VN Yuspa SH Selenoproteins are essential for proper keratinocyte function and skin development PLoS ONE 2010 5 e12249 10.1371/journal.pone.0012249 20805887
Sengupta A, Lichti UF, Carlson BA, Ryscavage AO, Gladyshev VN, Yuspa SH, et al. Selenoproteins are essential for proper keratinocyte function and skin development. PLoS ONE. 2010;5:e12249 10.1371/journal.pone.001224920805887 10.1371/journal.pone.0012249
33. Mehrotra P Ravichandran KS Drugging the efferocytosis process: concepts and opportunities Nat Rev Drug Discov 2022 21 601 20 10.1038/s41573-022-00470-y 35650427
Mehrotra P, Ravichandran KS. Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov. 2022;21:601–20. 10.1038/s41573-022-00470-y35650427 10.1038/s41573-022-00470-y
34. Pasparakis M Vandenabeele P Necroptosis and its role in inflammation Nature 2015 517 311 20 10.1038/nature14191 25592536
Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517:311–20. 10.1038/nature1419125592536 10.1038/nature14191
35. Newton K Dixit VM Kayagaki N Dying cells fan the flames of inflammation Science 2021 374 1076 80 10.1126/science.abi5934 34822265
Newton K, Dixit VM, Kayagaki N. Dying cells fan the flames of inflammation. Science. 2021;374:1076–80. 10.1126/science.abi593434822265 10.1126/science.abi5934
36. Lasry A Ben-Neriah Y Senescence-associated inflammatory responses: aging and cancer perspectives Trends Immunol 2015 36 217 28 10.1016/j.it.2015.02.009 25801910
Lasry A, Ben-Neriah Y. Senescence-associated inflammatory responses: aging and cancer perspectives. Trends Immunol. 2015;36:217–28. 10.1016/j.it.2015.02.00925801910 10.1016/j.it.2015.02.009
37. Upton JW Kaiser WJ Mocarski ES DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA Cell Host Microbe 2019 26 564 10.1016/j.chom.2019.09.004 31600504
Upton JW, Kaiser WJ, Mocarski ES. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe. 2019;26:564 10.1016/j.chom.2019.09.00431600504 10.1016/j.chom.2019.09.004
38. He S Wang L Miao L Wang T Du F Zhao L Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha Cell 2009 137 1100 11 10.1016/j.cell.2009.05.021 19524512
He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell. 2009;137:1100–11. 10.1016/j.cell.2009.05.02119524512 10.1016/j.cell.2009.05.021
39. Thapa RJ Nogusa S Chen P Maki JL Lerro A Andrake M Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases Proc Natl Acad Sci USA 2013 110 E3109 18 10.1073/pnas.1301218110 23898178
Thapa RJ, Nogusa S, Chen P, Maki JL, Lerro A, Andrake M, et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci USA. 2013;110:E3109–18. 10.1073/pnas.130121811023898178 10.1073/pnas.1301218110
40. Holler N Zaru R Micheau O Thome M Attinger A Valitutti S Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule Nat Immunol 2000 1 489 95 10.1038/82732 11101870
Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1:489–95. 10.1038/8273211101870 10.1038/82732
41. Feoktistova M Geserick P Kellert B Dimitrova DP Langlais C Hupe M cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms Mol Cell 2011 43 449 63 10.1016/j.molcel.2011.06.011 21737330
Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M, et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell. 2011;43:449–63. 10.1016/j.molcel.2011.06.01121737330 10.1016/j.molcel.2011.06.011
42. Cai Z Jitkaew S Zhao J Chiang HC Choksi S Liu J Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis Nat Cell Biol 2014 16 55 65 10.1038/ncb2883 24316671
Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol. 2014;16:55–65. 10.1038/ncb288324316671 10.1038/ncb2883
43. Kayagaki N Stowe IB Lee BL O’Rourke K Anderson K Warming S Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling Nature 2015 526 666 71 10.1038/nature15541 26375259
Kayagaki N, Stowe IB, Lee BL, O’Rourke K, Anderson K, Warming S, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526:666–71. 10.1038/nature1554126375259 10.1038/nature15541
44. Kayagaki N Kornfeld OS Lee BL Stowe IB O’Rourke K Li Q NINJ1 mediates plasma membrane rupture during lytic cell death Nature 2021 591 131 6 10.1038/s41586-021-03218-7 33472215
Kayagaki N, Kornfeld OS, Lee BL, Stowe IB, O’Rourke K, Li Q, et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature. 2021;591:131–6. 10.1038/s41586-021-03218-733472215 10.1038/s41586-021-03218-7
45. Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov. 2023. 10.1038/s41573-023-00822-2
46. Prochnicki T Vasconcelos MB Robinson KS Mangan MSJ De Graaf D Shkarina K Mitochondrial damage activates the NLRP10 inflammasome Nat Immunol 2023 24 595 603 10.1038/s41590-023-01451-y 36941400
Prochnicki T, Vasconcelos MB, Robinson KS, Mangan MSJ, De Graaf D, Shkarina K, et al. Mitochondrial damage activates the NLRP10 inflammasome. Nat Immunol. 2023;24:595–603. 10.1038/s41590-023-01451-y36941400 10.1038/s41590-023-01451-y
47. Wong SL Demers M Martinod K Gallant M Wang Y Goldfine AB Diabetes primes neutrophils to undergo NETosis, which impairs wound healing Nat Med 2015 21 815 9 10.1038/nm.3887 26076037
Wong SL, Demers M, Martinod K, Gallant M, Wang Y, Goldfine AB, et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med. 2015;21:815–9. 10.1038/nm.388726076037 10.1038/nm.3887
48. Shou Y Yang L Yang Y Xu J Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation Cell Death Dis 2021 12 1009 10.1038/s41419-021-04284-5 34707088
Shou Y, Yang L, Yang Y, Xu J. Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation. Cell Death Dis. 2021;12:1009 10.1038/s41419-021-04284-534707088 10.1038/s41419-021-04284-5
49. Chen L Min J Wang F Copper homeostasis and cuproptosis in health and disease Signal Transduct Target Ther 2022 7 378 10.1038/s41392-022-01229-y 36414625
Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7:378 10.1038/s41392-022-01229-y36414625 10.1038/s41392-022-01229-y
50. Hedgecock EM Sulston JE Thomson JN Mutations affecting programmed cell deaths in the nematode Caenorhabditis elegans Science 1983 220 1277 9 10.1126/science.6857247 6857247
Hedgecock EM, Sulston JE, Thomson JN. Mutations affecting programmed cell deaths in the nematode Caenorhabditis elegans. Science. 1983;220:1277–9. 10.1126/science.68572476857247 10.1126/science.6857247
51. Fuchs Y Steller H Programmed cell death in animal development and disease Cell 2011 147 742 58 10.1016/j.cell.2011.10.033 22078876
Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 2011;147:742–58. 10.1016/j.cell.2011.10.03322078876 10.1016/j.cell.2011.10.033
52. Lindsten T Ross AJ King A Zong WX Rathmell JC Shiels HA The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues Mol Cell 2000 6 1389 99 10.1016/s1097-2765(00)00136-2 11163212
Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell. 2000;6:1389–99. 10.1016/s1097-2765(00)00136-211163212 10.1016/s1097-2765(00)00136-2
53. Medina CB Mehrotra P Arandjelovic S Perry JSA Guo Y Morioka S Metabolites released from apoptotic cells act as tissue messengers Nature 2020 580 130 5 10.1038/s41586-020-2121-3 32238926
Medina CB, Mehrotra P, Arandjelovic S, Perry JSA, Guo Y, Morioka S, et al. Metabolites released from apoptotic cells act as tissue messengers. Nature. 2020;580:130–5. 10.1038/s41586-020-2121-332238926 10.1038/s41586-020-2121-3
54. Wyllie AH Kerr JF Currie AR Cell death: the significance of apoptosis Int Rev Cytol 1980 68 251 306 10.1016/s0074-7696(08)62312-8 7014501
Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. 10.1016/s0074-7696(08)62312-87014501 10.1016/s0074-7696(08)62312-8
55. Fadok VA Bratton DL Guthrie L Henson PM Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases J Immunol 2001 166 6847 54 10.4049/jimmunol.166.11.6847 11359844
Fadok VA, Bratton DL, Guthrie L, Henson PM. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J Immunol. 2001;166:6847–54. 10.4049/jimmunol.166.11.684711359844 10.4049/jimmunol.166.11.6847
56. Kim H Tu HC Ren D Takeuchi O Jeffers JR Zambetti GP Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis Mol Cell 2009 36 487 99 10.1016/j.molcel.2009.09.030 19917256
Kim H, Tu HC, Ren D, Takeuchi O, Jeffers JR, Zambetti GP, et al. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell. 2009;36:487–99. 10.1016/j.molcel.2009.09.03019917256 10.1016/j.molcel.2009.09.030
57. Liu X Kim CN Yang J Jemmerson R Wang X Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c Cell 1996 86 147 57 10.1016/s0092-8674(00)80085-9 8689682
Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996;86:147–57. 10.1016/s0092-8674(00)80085-98689682 10.1016/s0092-8674(00)80085-9
58. Sotiropoulou PA Candi A Mascre G De Clercq S Youssef KK Lapouge G Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death Nat Cell Biol 2010 12 572 82 10.1038/ncb2059 20473297
Sotiropoulou PA, Candi A, Mascre G, De Clercq S, Youssef KK, Lapouge G, et al. Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat Cell Biol. 2010;12:572–82. 10.1038/ncb205920473297 10.1038/ncb2059
59. Geueke A Mantellato G Kuester F Schettina P Nelles M Seeger JM The anti-apoptotic Bcl-2 protein regulates hair follicle stem cell function EMBO Rep 2021 22 e52301 10.15252/embr.202052301 34342114
Geueke A, Mantellato G, Kuester F, Schettina P, Nelles M, Seeger JM, et al. The anti-apoptotic Bcl-2 protein regulates hair follicle stem cell function. EMBO Rep. 2021;22:e52301 10.15252/embr.20205230134342114 10.15252/embr.202052301
60. Yusupova M Ankawa R Yosefzon Y Meiri D Bachelet I Fuchs Y Apoptotic dysregulation mediates stem cell competition and tissue regeneration Nat Commun 2023 14 7547 10.1038/s41467-023-41684-x 37985759
Yusupova M, Ankawa R, Yosefzon Y, Meiri D, Bachelet I, Fuchs Y. Apoptotic dysregulation mediates stem cell competition and tissue regeneration. Nat Commun. 2023;14:7547 10.1038/s41467-023-41684-x37985759 10.1038/s41467-023-41684-x
61. van Loo G Bertrand MJM Death by TNF: a road to inflammation Nat Rev Immunol 2023 23 289 303 10.1038/s41577-022-00792-3 36380021
van Loo G, Bertrand MJM. Death by TNF: a road to inflammation. Nat Rev Immunol. 2023;23:289–303. 10.1038/s41577-022-00792-336380021 10.1038/s41577-022-00792-3
62. Newton K Wickliffe KE Dugger DL Maltzman A Roose-Girma M Dohse M Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis Nature 2019 574 428 31 10.1038/s41586-019-1548-x 31511692
Newton K, Wickliffe KE, Dugger DL, Maltzman A, Roose-Girma M, Dohse M, et al. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature. 2019;574:428–31. 10.1038/s41586-019-1548-x31511692 10.1038/s41586-019-1548-x
63. Chen KW, Demarco B, Heilig R, Shkarina K, Boettcher A, Farady CJ, et al. Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly. EMBO J. 2019;38. 10.15252/embj.2019101638
64. Newton K Wickliffe KE Maltzman A Dugger DL Reja R Zhang Y Activity of caspase-8 determines plasticity between cell death pathways Nature 2019 575 679 82 10.1038/s41586-019-1752-8 31723262
Newton K, Wickliffe KE, Maltzman A, Dugger DL, Reja R, Zhang Y, et al. Activity of caspase-8 determines plasticity between cell death pathways. Nature. 2019;575:679–82. 10.1038/s41586-019-1752-831723262 10.1038/s41586-019-1752-8
65. Pasparakis M Courtois G Hafner M Schmidt-Supprian M Nenci A Toksoy A TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 Nature 2002 417 861 866 10.1038/nature00820 12075355
Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A, et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature. 2002;417:861–866. 10.1038/nature0082012075355 10.1038/nature00820
66. Panayotova-Dimitrova D Feoktistova M Ploesser M Kellert B Hupe M Horn S cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis Cell Rep 2013 5 397 408 10.1016/j.celrep.2013.09.035 24209745
Panayotova-Dimitrova D, Feoktistova M, Ploesser M, Kellert B, Hupe M, Horn S, et al. cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis. Cell Rep. 2013;5:397–408. 10.1016/j.celrep.2013.09.03524209745 10.1016/j.celrep.2013.09.035
67. Weinlich R Oberst A Dillon CP Janke LJ Milasta S Lukens JR Protective roles for caspase-8 and cFLIP in adult homeostasis Cell Rep 2013 5 340 348 10.1016/j.celrep.2013.08.045 24095739
Weinlich R, Oberst A, Dillon CP, Janke LJ, Milasta S, Lukens JR, et al. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell Rep. 2013;5:340–348. 10.1016/j.celrep.2013.08.04524095739 10.1016/j.celrep.2013.08.045
68. Grinberg-Bleyer Y Dainichi T Oh H Heise N Klein U Schmid RM Cutting edge: NF-kappaB p65 and c-Rel control epidermal development and immune homeostasis in the skin J Immunol 2015 194 2472 2476 10.4049/jimmunol.1402608 25681334
Grinberg-Bleyer Y, Dainichi T, Oh H, Heise N, Klein U, Schmid RM, et al. Cutting edge: NF-kappaB p65 and c-Rel control epidermal development and immune homeostasis in the skin. J Immunol. 2015;194:2472–2476. 10.4049/jimmunol.140260825681334 10.4049/jimmunol.1402608
69. Omori E Matsumoto K Sanjo H Sato S Akira S Smart RC TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis J Biol Chem 2006 281 19610 17 10.1074/jbc.M603384200 16675448
Omori E, Matsumoto K, Sanjo H, Sato S, Akira S, Smart RC, et al. TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J Biol Chem. 2006;281:19610–17. 10.1074/jbc.M60338420016675448 10.1074/jbc.M603384200
70. Nenci A Huth M Funteh A Schmidt-Supprian M Bloch W Metzger D Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling Hum Mol Genet 2006 15 531 42 10.1093/hmg/ddi470 16399796
Nenci A, Huth M, Funteh A, Schmidt-Supprian M, Bloch W, Metzger D, et al. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum Mol Genet. 2006;15:531–42. 10.1093/hmg/ddi47016399796 10.1093/hmg/ddi470
71. Gareus R Huth M Breiden B Nenci A Rosch N Haase I Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation Nat Cell Biol 2007 9 461 9 10.1038/ncb1560 17351639
Gareus R, Huth M, Breiden B, Nenci A, Rosch N, Haase I, et al. Normal epidermal differentiation but impaired skin-barrier formation upon keratinocyte-restricted IKK1 ablation. Nat Cell Biol. 2007;9:461–9. 10.1038/ncb156017351639 10.1038/ncb1560
72. Lippens S Lefebvre S Gilbert B Sze M Devos M Verhelst K Keratinocyte-specific ablation of the NF-kappaB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis Cell Death Differ 2011 18 1845 53 10.1038/cdd.2011.55 21566665
Lippens S, Lefebvre S, Gilbert B, Sze M, Devos M, Verhelst K, et al. Keratinocyte-specific ablation of the NF-kappaB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis. Cell Death Differ. 2011;18:1845–53. 10.1038/cdd.2011.5521566665 10.1038/cdd.2011.55
73. Etemadi N, Chopin M, Anderton H, Tanzer MC, Rickard JA, Abeysekera W, et al. TRAF2 regulates TNF and NF-kappaB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1. Elife. 2015;4. 10.7554/eLife.10592
74. Smahi A Courtois G Rabia SH Doffinger R Bodemer C Munnich A The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes Hum Mol Genet 2002 11 2371 5 10.1093/hmg/11.20.2371 12351572
Smahi A, Courtois G, Rabia SH, Doffinger R, Bodemer C, Munnich A, et al. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet. 2002;11:2371–5. 10.1093/hmg/11.20.237112351572 10.1093/hmg/11.20.2371
75. Newton K Wickliffe KE Maltzman A Dugger DL Strasser A Pham VC RIPK1 inhibits ZBP1-driven necroptosis during development Nature 2016 540 129 33 10.1038/nature20559 27819682
Newton K, Wickliffe KE, Maltzman A, Dugger DL, Strasser A, Pham VC, et al. RIPK1 inhibits ZBP1-driven necroptosis during development. Nature. 2016;540:129–33. 10.1038/nature2055927819682 10.1038/nature20559
76. Lin J Kumari S Kim C Van TM Wachsmuth L Polykratis A RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation Nature 2016 540 124 8 10.1038/nature20558 27819681
Lin J, Kumari S, Kim C, Van TM, Wachsmuth L, Polykratis A, et al. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature. 2016;540:124–8. 10.1038/nature2055827819681 10.1038/nature20558
77. Devos M, Tanghe G, Gilbert B, Dierick E, Verheirstraeten M, Nemegeer J, et al. Sensing of endogenous nucleic acids by ZBP1 induces keratinocyte necroptosis and skin inflammation. J Exp Med. 2020;217. 10.1084/jem.20191913
78. Hoste E, Lecomte K, Annusver K, Vandamme N, Roels J, Maschalidi S, et al. OTULIN maintains skin homeostasis by controlling keratinocyte death and stem cell identity. Nat Commun. 2021;12:5913. 10.1038/s41467-021-25944-2
79. Taraborrelli L Peltzer N Montinaro A Kupka S Rieser E Hartwig T LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L Nat Commun 2018 9 3910 10.1038/s41467-018-06155-8 30254289
Taraborrelli L, Peltzer N, Montinaro A, Kupka S, Rieser E, Hartwig T, et al. LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L. Nat Commun. 2018;9:3910 10.1038/s41467-018-06155-830254289 10.1038/s41467-018-06155-8
80. Cockram PE Kist M Prakash S Chen SH Wertz IE Vucic D Ubiquitination in the regulation of inflammatory cell death and cancer Cell Death Differ 2021 28 591 605 10.1038/s41418-020-00708-5 33432113
Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28:591–605. 10.1038/s41418-020-00708-533432113 10.1038/s41418-020-00708-5
81. Peltzer N Darding M Montinaro A Draber P Draberova H Kupka S LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis Nature 2018 557 112 7 10.1038/s41586-018-0064-8 29695863
Peltzer N, Darding M, Montinaro A, Draber P, Draberova H, Kupka S, et al. LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis. Nature. 2018;557:112–7. 10.1038/s41586-018-0064-829695863 10.1038/s41586-018-0064-8
82. Damgaard RB Walker JA Marco-Casanova P Morgan NV Titheradge HL Elliott PR The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity Cell 2016 166 1215 30 e1220 10.1016/j.cell.2016.07.019 27523608
Damgaard RB, Walker JA, Marco-Casanova P, Morgan NV, Titheradge HL, Elliott PR, et al. The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity. Cell. 2016;166:1215–30 e1220. 10.1016/j.cell.2016.07.01927523608 10.1016/j.cell.2016.07.019
83. Komander D Reyes-Turcu F Licchesi JD Odenwaelder P Wilkinson KD Barford D Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains EMBO Rep 2009 10 466 73 10.1038/embor.2009.55 19373254
Komander D, Reyes-Turcu F, Licchesi JD, Odenwaelder P, Wilkinson KD, Barford D. Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 2009;10:466–73. 10.1038/embor.2009.5519373254 10.1038/embor.2009.55
84. Gerlach B Cordier SM Schmukle AC Emmerich CH Rieser E Haas TL Linear ubiquitination prevents inflammation and regulates immune signalling Nature 2011 471 591 6 10.1038/nature09816 21455173
Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature. 2011;471:591–6. 10.1038/nature0981621455173 10.1038/nature09816
85. Keusekotten K Elliott PR Glockner L Fiil BK Damgaard RB Kulathu Y OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin Cell 2013 153 1312 26 10.1016/j.cell.2013.05.014 23746843
Keusekotten K, Elliott PR, Glockner L, Fiil BK, Damgaard RB, Kulathu Y, et al. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell. 2013;153:1312–26. 10.1016/j.cell.2013.05.01423746843 10.1016/j.cell.2013.05.014
86. HogenEsch H Gijbels MJ Offerman E van Hooft J van Bekkum DW Zurcher C A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice Am J Pathol 1993 143 972 82 8362989
HogenEsch H, Gijbels MJ, Offerman E, van Hooft J, van Bekkum DW, Zurcher C. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am J Pathol. 1993;143:972–82.8362989
87. Schunke H Gobel U Dikic I Pasparakis M OTULIN inhibits RIPK1-mediated keratinocyte necroptosis to prevent skin inflammation in mice Nat Commun 2021 12 5912 10.1038/s41467-021-25945-1 34625557
Schunke H, Gobel U, Dikic I, Pasparakis M. OTULIN inhibits RIPK1-mediated keratinocyte necroptosis to prevent skin inflammation in mice. Nat Commun. 2021;12:5912 10.1038/s41467-021-25945-134625557 10.1038/s41467-021-25945-1
88. Sundberg JP Pratt CH Goodwin LP Silva KA Kennedy VE Potter CS Keratinocyte-specific deletion of SHARPIN induces atopic dermatitis-like inflammation in mice PLoS ONE 2020 15 e0235295 10.1371/journal.pone.0235295 32687504
Sundberg JP, Pratt CH, Goodwin LP, Silva KA, Kennedy VE, Potter CS, et al. Keratinocyte-specific deletion of SHARPIN induces atopic dermatitis-like inflammation in mice. PLoS ONE. 2020;15:e0235295 10.1371/journal.pone.023529532687504 10.1371/journal.pone.0235295
89. Damgaard RB, Elliott PR, Swatek KN, Maher ER, Stepensky P, Elpeleg O, et al. OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death. EMBO Mol Med. 2019;11. 10.15252/emmm.201809324
90. Verboom L Anderson CJ Jans M Petta I Blancke G Martens A OTULIN protects the intestinal epithelium from apoptosis during inflammation and infection Cell Death Dis 2023 14 534 10.1038/s41419-023-06058-7 37598207
Verboom L, Anderson CJ, Jans M, Petta I, Blancke G, Martens A, et al. OTULIN protects the intestinal epithelium from apoptosis during inflammation and infection. Cell Death Dis. 2023;14:534 10.1038/s41419-023-06058-737598207 10.1038/s41419-023-06058-7
91. Duan X Liu X Liu N Huang Y Jin Z Zhang S Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation Cell Death Dis 2020 11 134 10.1038/s41419-020-2328-0 32075957
Duan X, Liu X, Liu N, Huang Y, Jin Z, Zhang S, et al. Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation. Cell Death Dis. 2020;11:134 10.1038/s41419-020-2328-032075957 10.1038/s41419-020-2328-0
92. Zhang K Anumanthan G Scheaffer S Cornelius LA HMGB1/RAGE mediates UVB-induced secretory inflammatory response and resistance to apoptosis in human melanocytes J Investig Dermatol 2019 139 202 12 10.1016/j.jid.2018.05.035 30030153
Zhang K, Anumanthan G, Scheaffer S, Cornelius LA. HMGB1/RAGE mediates UVB-induced secretory inflammatory response and resistance to apoptosis in human melanocytes. J Investig Dermatol. 2019;139:202–12. 10.1016/j.jid.2018.05.03530030153 10.1016/j.jid.2018.05.035
93. Nair RP Duffin KC Helms C Ding J Stuart PE Goldgar D Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways Nat Genet 2009 41 199 204 10.1038/ng.311 19169254
Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41:199–204. 10.1038/ng.31119169254 10.1038/ng.311
94. Tsoi LC Stuart PE Tian C Gudjonsson JE Das S Zawistowski M Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants Nat Commun 2017 8 15382 10.1038/ncomms15382 28537254
Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, Zawistowski M, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun. 2017;8:15382 10.1038/ncomms1538228537254 10.1038/ncomms15382
95. Betz RC Petukhova L Ripke S Huang H Menelaou A Redler S Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci Nat Commun 2015 6 5966 10.1038/ncomms6966 25608926
Betz RC, Petukhova L, Ripke S, Huang H, Menelaou A, Redler S, et al. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun. 2015;6:5966 10.1038/ncomms696625608926 10.1038/ncomms6966
96. Mease PJ Goffe BS Metz J VanderStoep A Finck B Burge DJ Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial Lancet 2000 356 385 90 10.1016/S0140-6736(00)02530-7 10972371
Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 2000;356:385–90. 10.1016/S0140-6736(00)02530-710972371 10.1016/S0140-6736(00)02530-7
97. Honda T Yamamoto O Sawada Y Egawa G Kitoh A Otsuka A Receptor-interacting protein kinase 3 controls keratinocyte activation in a necroptosis-independent manner and promotes psoriatic dermatitis in mice J Allergy Clin Immunol 2017 140 619 22 e616 10.1016/j.jaci.2017.02.027 28342910
Honda T, Yamamoto O, Sawada Y, Egawa G, Kitoh A, Otsuka A, et al. Receptor-interacting protein kinase 3 controls keratinocyte activation in a necroptosis-independent manner and promotes psoriatic dermatitis in mice. J Allergy Clin Immunol. 2017;140:619–22 e616. 10.1016/j.jaci.2017.02.02728342910 10.1016/j.jaci.2017.02.027
98. Weisel K Berger S Papp K Maari C Krueger JG Scott N Response to inhibition of receptor-interacting protein kinase 1 (RIPK1) in active plaque psoriasis: a randomized placebo-controlled study Clin Pharmacol Ther 2020 108 808 16 10.1002/cpt.1852 32301501
Weisel K, Berger S, Papp K, Maari C, Krueger JG, Scott N, et al. Response to inhibition of receptor-interacting protein kinase 1 (RIPK1) in active plaque psoriasis: a randomized placebo-controlled study. Clin Pharmacol Ther. 2020;108:808–16. 10.1002/cpt.185232301501 10.1002/cpt.1852
99. Sato H Koide T Masuya H Wakana S Sagai T Umezawa A A new mutation Rim3 resembling Re(den) is mapped close to retinoic acid receptor alpha (Rara) gene on mouse chromosome 11 Mamm Genome 1998 9 20 25 10.1007/s003359900673 9434940
Sato H, Koide T, Masuya H, Wakana S, Sagai T, Umezawa A, et al. A new mutation Rim3 resembling Re(den) is mapped close to retinoic acid receptor alpha (Rara) gene on mouse chromosome 11. Mamm Genome. 1998;9:20–25. 10.1007/s0033599006739434940 10.1007/s003359900673
100. Ding J Wang K Liu W She Y Sun Q Shi J Pore-forming activity and structural autoinhibition of the gasdermin family Nature 2016 535 111 6 10.1038/nature18590 27281216
Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535:111–6. 10.1038/nature1859027281216 10.1038/nature18590
101. Liu X Zhang Z Ruan J Pan Y Magupalli VG Wu H Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores Nature 2016 535 153 8 10.1038/nature18629 27383986
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153–8. 10.1038/nature1862927383986 10.1038/nature18629
102. Aglietti RA Estevez A Gupta A Ramirez MG Liu PS Kayagaki N GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes Proc Natl Acad Sci USA 2016 113 7858 63 10.1073/pnas.1607769113 27339137
Aglietti RA, Estevez A, Gupta A, Ramirez MG, Liu PS, Kayagaki N, et al. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci USA. 2016;113:7858–63. 10.1073/pnas.160776911327339137 10.1073/pnas.1607769113
103. Zhong FL Mamai O Sborgi L Boussofara L Hopkins R Robinson K Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation Cell 2016 167 187 202 e117 10.1016/j.cell.2016.09.001 27662089
Zhong FL, Mamai O, Sborgi L, Boussofara L, Hopkins R, Robinson K, et al. Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell. 2016;167:187–202 e117. 10.1016/j.cell.2016.09.00127662089 10.1016/j.cell.2016.09.001
104. Drutman SB Haerynck F Zhong FL Hum D Hernandez NJ Belkaya S Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis Proc Natl Acad Sci USA 2019 116 19055 63 10.1073/pnas.1906184116 31484767
Drutman SB, Haerynck F, Zhong FL, Hum D, Hernandez NJ, Belkaya S, et al. Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis. Proc Natl Acad Sci USA. 2019;116:19055–63. 10.1073/pnas.190618411631484767 10.1073/pnas.1906184116
105. Mamai O Boussofara L Denguezli M Escande-Beillard N Kraeim W Merriman B Multiple self-healing palmoplantar carcinoma: a familial predisposition to skin cancer with primary palmoplantar and conjunctival lesions J Invest Dermatol 2015 135 304 8 10.1038/jid.2014.311 25050600
Mamai O, Boussofara L, Denguezli M, Escande-Beillard N, Kraeim W, Merriman B, et al. Multiple self-healing palmoplantar carcinoma: a familial predisposition to skin cancer with primary palmoplantar and conjunctival lesions. J Invest Dermatol. 2015;135:304–8. 10.1038/jid.2014.31125050600 10.1038/jid.2014.311
106. Harapas CR Robinson KS Lay K Wong J Moreno Traspas R Nabavizadeh N DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling Sci Immunol 2022 7 eabi4611 10.1126/sciimmunol.abi4611 36112693
Harapas CR, Robinson KS, Lay K, Wong J, Moreno Traspas R, Nabavizadeh N, et al. DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling. Sci Immunol. 2022;7:eabi4611 10.1126/sciimmunol.abi461136112693 10.1126/sciimmunol.abi4611
107. Hoffman HM Mueller JL Broide DH Wanderer AA Kolodner RD Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome Nat Genet 2001 29 301 5 10.1038/ng756 11687797
Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29:301–5. 10.1038/ng75611687797 10.1038/ng756
108. Brydges SD Mueller JL McGeough MD Pena CA Misaghi A Gandhi C Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity Immunity 2009 30 875 87 10.1016/j.immuni.2009.05.005 19501000
Brydges SD, Mueller JL, McGeough MD, Pena CA, Misaghi A, Gandhi C, et al. Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity. 2009;30:875–87. 10.1016/j.immuni.2009.05.00519501000 10.1016/j.immuni.2009.05.005
109. Meng G Zhang F Fuss I Kitani A Strober W A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses Immunity 2009 30 860 74 10.1016/j.immuni.2009.04.012 19501001
Meng G, Zhang F, Fuss I, Kitani A, Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity. 2009;30:860–74. 10.1016/j.immuni.2009.04.01219501001 10.1016/j.immuni.2009.04.012
110. Xiao J Wang C Yao JC Alippe Y Xu C Kress D Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice PLoS Biol 2018 16 e3000047 10.1371/journal.pbio.3000047 30388107
Xiao J, Wang C, Yao JC, Alippe Y, Xu C, Kress D, et al. Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice. PLoS Biol. 2018;16:e3000047 10.1371/journal.pbio.300004730388107 10.1371/journal.pbio.3000047
111. Chen Y Lian N Chen S Xiao T Ke Y Zhang Y GSDME deficiency leads to the aggravation of UVB-induced skin inflammation through enhancing recruitment and activation of neutrophils Cell Death Dis 2022 13 841 10.1038/s41419-022-05276-9 36182937
Chen Y, Lian N, Chen S, Xiao T, Ke Y, Zhang Y, et al. GSDME deficiency leads to the aggravation of UVB-induced skin inflammation through enhancing recruitment and activation of neutrophils. Cell Death Dis. 2022;13:841 10.1038/s41419-022-05276-936182937 10.1038/s41419-022-05276-9
112. Orzalli MH Prochera A Payne L Smith A Garlick JA Kagan JC Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells Immunity 2021 54 1447 62 e1445 10.1016/j.immuni.2021.04.012 33979579
Orzalli MH, Prochera A, Payne L, Smith A, Garlick JA, Kagan JC. Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells. Immunity. 2021;54:1447–62 e1445. 10.1016/j.immuni.2021.04.01233979579 10.1016/j.immuni.2021.04.012
113. Masters SL Lagou V Jeru I Baker PJ Van Eyck L Parry DA Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation Sci Transl Med 2016 8 332ra345 10.1126/scitranslmed.aaf1471
Masters SL, Lagou V, Jeru I, Baker PJ, Van Eyck L, Parry DA, et al. Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. Sci Transl Med. 2016;8:332ra345 10.1126/scitranslmed.aaf147110.1126/scitranslmed.aaf1471
114. Zuo X Sun L Yin X Gao J Sheng Y Xu J Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis Nat Commun 2015 6 6793 10.1038/ncomms7793 25854761
Zuo X, Sun L, Yin X, Gao J, Sheng Y, Xu J, et al. Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis. Nat Commun. 2015;6:6793 10.1038/ncomms779325854761 10.1038/ncomms7793
115. Naik S Larsen SB Gomez NC Alaverdyan K Sendoel A Yuan S Inflammatory memory sensitizes skin epithelial stem cells to tissue damage Nature 2017 550 475 80 10.1038/nature24271 29045388
Naik S, Larsen SB, Gomez NC, Alaverdyan K, Sendoel A, Yuan S, et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature. 2017;550:475–80. 10.1038/nature2427129045388 10.1038/nature24271
116. Damm A Giebeler N Zamek J Zigrino P Kufer TA Epidermal NLRP10 contributes to contact hypersensitivity responses in mice Eur J Immunol 2016 46 1959 69 10.1002/eji.201646401 27221772
Damm A, Giebeler N, Zamek J, Zigrino P, Kufer TA. Epidermal NLRP10 contributes to contact hypersensitivity responses in mice. Eur J Immunol. 2016;46:1959–69. 10.1002/eji.20164640127221772 10.1002/eji.201646401
117. Koska MC Karadag AS Durdu M Annular neutrophilic dermatoses Clin Dermatol 2023 41 340 54 10.1016/j.clindermatol.2023.07.003 37423267
Koska MC, Karadag AS, Durdu M. Annular neutrophilic dermatoses. Clin Dermatol. 2023;41:340–54. 10.1016/j.clindermatol.2023.07.00337423267 10.1016/j.clindermatol.2023.07.003
118. Zarchi K Dufour DN Jemec GB Successful treatment of severe hidradenitis suppurativa with anakinra JAMA Dermatol 2013 149 1192 4 10.1001/jamadermatol.2013.5377 23966107
Zarchi K, Dufour DN, Jemec GB. Successful treatment of severe hidradenitis suppurativa with anakinra. JAMA Dermatol. 2013;149:1192–4. 10.1001/jamadermatol.2013.537723966107 10.1001/jamadermatol.2013.5377
119. Calabrese L Fiocco Z Satoh TK Peris K French LE Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases Br J Dermatol 2022 186 925 41 10.1111/bjd.20975 34990008
Calabrese L, Fiocco Z, Satoh TK, Peris K, French LE. Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases. Br J Dermatol. 2022;186:925–41. 10.1111/bjd.2097534990008 10.1111/bjd.20975
120. Jiang X Stockwell BR Conrad M Ferroptosis: mechanisms, biology and role in disease Nat Rev Mol Cell Biol 2021 22 266 82 10.1038/s41580-020-00324-8 33495651
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266–82. 10.1038/s41580-020-00324-833495651 10.1038/s41580-020-00324-8
121. Dixon SJ Lemberg KM Lamprecht MR Skouta R Zaitsev EM Gleason CE Ferroptosis: an iron-dependent form of nonapoptotic cell death Cell 2012 149 1060 72 10.1016/j.cell.2012.03.042 22632970
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–72. 10.1016/j.cell.2012.03.04222632970 10.1016/j.cell.2012.03.042
122. Li J Cao F Yin HL Huang ZJ Lin ZT Mao N Ferroptosis: past, present and future Cell Death Dis 2020 11 88 10.1038/s41419-020-2298-2 32015325
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88 10.1038/s41419-020-2298-232015325 10.1038/s41419-020-2298-2
123. Seiler A Schneider M Forster H Roth S Wirth EK Culmsee C Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death Cell Metab 2008 8 237 48 10.1016/j.cmet.2008.07.005 18762024
Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8:237–48. 10.1016/j.cmet.2008.07.00518762024 10.1016/j.cmet.2008.07.005
124. Sengupta A Lichti UF Carlson BA Cataisson C Ryscavage AO Mikulec C Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2 J Investig Dermatol 2013 133 1731 41 10.1038/jid.2013.52 23364477
Sengupta A, Lichti UF, Carlson BA, Cataisson C, Ryscavage AO, Mikulec C, et al. Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2. J Investig Dermatol. 2013;133:1731–41. 10.1038/jid.2013.5223364477 10.1038/jid.2013.52
125. Dikic I Elazar Z Mechanism and medical implications of mammalian autophagy Nat Rev Mol Cell Biol 2018 19 349 64 10.1038/s41580-018-0003-4 29618831
Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19:349–64. 10.1038/s41580-018-0003-429618831 10.1038/s41580-018-0003-4
126. Rossiter H Konig U Barresi C Buchberger M Ghannadan M Zhang CF Epidermal keratinocytes form a functional skin barrier in the absence of Atg7 dependent autophagy J Dermatol Sci 2013 71 67 75 10.1016/j.jdermsci.2013.04.015 23669018
Rossiter H, Konig U, Barresi C, Buchberger M, Ghannadan M, Zhang CF, et al. Epidermal keratinocytes form a functional skin barrier in the absence of Atg7 dependent autophagy. J Dermatol Sci. 2013;71:67–75. 10.1016/j.jdermsci.2013.04.01523669018 10.1016/j.jdermsci.2013.04.015
127. Song X Narzt MS Nagelreiter IM Hohensinner P Terlecki-Zaniewicz L Tschachler E Autophagy deficient keratinocytes display increased DNA damage, senescence and aberrant lipid composition after oxidative stress in vitro and in vivo Redox Biol 2017 11 219 30 10.1016/j.redox.2016.12.015 28012437
Song X, Narzt MS, Nagelreiter IM, Hohensinner P, Terlecki-Zaniewicz L, Tschachler E, et al. Autophagy deficient keratinocytes display increased DNA damage, senescence and aberrant lipid composition after oxidative stress in vitro and in vivo. Redox Biol. 2017;11:219–30. 10.1016/j.redox.2016.12.01528012437 10.1016/j.redox.2016.12.015
128. Huyghe J Priem D Van Hove L Gilbert B Fritsch J Uchiyama Y ATG9A prevents TNF cytotoxicity by an unconventional lysosomal targeting pathway Science 2022 378 1201 7 10.1126/science.add6967 36520901
Huyghe J, Priem D, Van Hove L, Gilbert B, Fritsch J, Uchiyama Y, et al. ATG9A prevents TNF cytotoxicity by an unconventional lysosomal targeting pathway. Science. 2022;378:1201–7. 10.1126/science.add696736520901 10.1126/science.add6967
129. Douroudis K Kingo K Traks T Ratsep R Silm H Vasar E ATG16L1 gene polymorphisms are associated with palmoplantar pustulosis Hum Immunol 2011 72 613 5 10.1016/j.humimm.2011.03.009 21513755
Douroudis K, Kingo K, Traks T, Ratsep R, Silm H, Vasar E, et al. ATG16L1 gene polymorphisms are associated with palmoplantar pustulosis. Hum Immunol. 2011;72:613–5. 10.1016/j.humimm.2011.03.00921513755 10.1016/j.humimm.2011.03.009
130. Douroudis K Kingo K Traks T Reimann E Raud K Ratsep R Polymorphisms in the ATG16L1 gene are associated with psoriasis vulgaris Acta Derm Venereol 2012 92 85 87 10.2340/00015555-1183 21879234
Douroudis K, Kingo K, Traks T, Reimann E, Raud K, Ratsep R, et al. Polymorphisms in the ATG16L1 gene are associated with psoriasis vulgaris. Acta Derm Venereol. 2012;92:85–87. 10.2340/00015555-118321879234 10.2340/00015555-1183
131. Arwert EN Hoste E Watt FM Epithelial stem cells, wound healing and cancer Nat Rev Cancer 2012 12 170 80 10.1038/nrc3217 22362215
Arwert EN, Hoste E, Watt FM. Epithelial stem cells, wound healing and cancer. Nat Rev Cancer. 2012;12:170–80. 10.1038/nrc321722362215 10.1038/nrc3217
132. Hoste E Maueroder C van Hove L Catrysse L Vikkula HK Sze M Epithelial HMGB1 delays skin wound healing and drives tumor initiation by priming neutrophils for NET formation Cell Rep 2019 29 2689 701 e2684 10.1016/j.celrep.2019.10.104 31775038
Hoste E, Maueroder C, van Hove L, Catrysse L, Vikkula HK, Sze M, et al. Epithelial HMGB1 delays skin wound healing and drives tumor initiation by priming neutrophils for NET formation. Cell Rep. 2019;29:2689–701 e2684. 10.1016/j.celrep.2019.10.10431775038 10.1016/j.celrep.2019.10.104
133. Menegazzo L Ciciliot S Poncina N Mazzucato M Persano M Bonora B NETosis is induced by high glucose and associated with type 2 diabetes Acta Diabetol 2015 52 497 503 10.1007/s00592-014-0676-x 25387570
Menegazzo L, Ciciliot S, Poncina N, Mazzucato M, Persano M, Bonora B, et al. NETosis is induced by high glucose and associated with type 2 diabetes. Acta Diabetol. 2015;52:497–503. 10.1007/s00592-014-0676-x25387570 10.1007/s00592-014-0676-x
134. Mees MA, Boone F, Bouwen T, Vanaerschot F, Titeca C, Vikkula HK, et al. Glycyrrhizin-based hydrogels accelerate wound healing of normoglycemic and diabetic mouse skin. Pharmaceutics. 2022;15. 10.3390/pharmaceutics15010027
135. Injarabian L, Willenborg S, Welcker D, Sanin DE, Pasparakis M, Kashkar H, et al. FADD- and RIPK3-mediated cell death ensures clearance of Ly6C(high) wound macrophages from damaged tissue. J Investig Dermatol. 2023. 10.1016/j.jid.2023.06.203
136. Li F Huang Q Chen J Peng Y Roop DR Bedford JS Apoptotic cells activate the “phoenix rising” pathway to promote wound healing and tissue regeneration Sci Signal 2010 3 ra13 10.1126/scisignal.2000634 20179271
Li F, Huang Q, Chen J, Peng Y, Roop DR, Bedford JS, et al. Apoptotic cells activate the “phoenix rising” pathway to promote wound healing and tissue regeneration. Sci Signal. 2010;3:ra13 10.1126/scisignal.200063420179271 10.1126/scisignal.2000634
137. Fuchs Y Brown S Gorenc T Rodriguez J Fuchs E Steller H Sept4/ARTS regulates stem cell apoptosis and skin regeneration Science 2013 341 286 9 10.1126/science.1233029 23788729
Fuchs Y, Brown S, Gorenc T, Rodriguez J, Fuchs E, Steller H. Sept4/ARTS regulates stem cell apoptosis and skin regeneration. Science. 2013;341:286–9. 10.1126/science.123302923788729 10.1126/science.1233029
138. Martinez Lagunas K Savcigil DP Zrilic M Carvajal Fraile C Craxton A Self E Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair Sci Adv 2023 9 eadg2829 10.1126/sciadv.adg2829 37494451
Martinez Lagunas K, Savcigil DP, Zrilic M, Carvajal Fraile C, Craxton A, Self E, et al. Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair. Sci Adv. 2023;9:eadg2829 10.1126/sciadv.adg282937494451 10.1126/sciadv.adg2829
139. Ankawa R Goldberger N Yosefzon Y Koren E Yusupova M Rosner D Apoptotic cells represent a dynamic stem cell niche governing proliferation and tissue regeneration Dev Cell 2021 56 1900 16.e1905 10.1016/j.devcel.2021.06.008 34197726
Ankawa R, Goldberger N, Yosefzon Y, Koren E, Yusupova M, Rosner D, et al. Apoptotic cells represent a dynamic stem cell niche governing proliferation and tissue regeneration. Dev Cell. 2021;56:1900–16.e1905. 10.1016/j.devcel.2021.06.00834197726 10.1016/j.devcel.2021.06.008
140. Maschalidi S Mehrotra P Keceli BN De Cleene HKL Lecomte K Van der Cruyssen R Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes Nature 2022 606 776 84 10.1038/s41586-022-04754-6 35614212
Maschalidi S, Mehrotra P, Keceli BN, De Cleene HKL, Lecomte K, Van der Cruyssen R, et al. Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes. Nature. 2022;606:776–84. 10.1038/s41586-022-04754-635614212 10.1038/s41586-022-04754-6
141. Justynski O, Bridges K, Krause W, Forni MF, Phan QM, Sandoval-Schaefer T, et al. Apoptosis recognition receptors regulate skin tissue repair in mice. Elife. 2023;12. 10.7554/eLife.86269
142. Silva MT Secondary necrosis: the natural outcome of the complete apoptotic program FEBS Lett 2010 584 4491 9 10.1016/j.febslet.2010.10.046 20974143
Silva MT. Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett. 2010;584:4491–9. 10.1016/j.febslet.2010.10.04620974143 10.1016/j.febslet.2010.10.046
143. Stewart KS, Gonzales KA, Yuan S, Tierney MT, Bonny AR, Yang Y, et al. Stem cells tightly regulate dead cell clearance to maintain tissue fitness. bioRxiv. 2023. 10.1101/2023.05.22.541773
144. Brock CK Wallin ST Ruiz OE Samms KM Mandal A Sumner EA Stem cell proliferation is induced by apoptotic bodies from dying cells during epithelial tissue maintenance Nat Commun 2019 10 1044 10.1038/s41467-019-09010-6 30837472
Brock CK, Wallin ST, Ruiz OE, Samms KM, Mandal A, Sumner EA, et al. Stem cell proliferation is induced by apoptotic bodies from dying cells during epithelial tissue maintenance. Nat Commun. 2019;10:1044 10.1038/s41467-019-09010-630837472 10.1038/s41467-019-09010-6
145. Huang Q Li F Liu X Li W Shi W Liu FF Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy Nat Med 2011 17 860 6 10.1038/nm.2385 21725296
Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med. 2011;17:860–6. 10.1038/nm.238521725296 10.1038/nm.2385
146. Berthenet K Castillo Ferrer C Fanfone D Popgeorgiev N Neves D Bertolino P Failed apoptosis enhances melanoma cancer cell aggressiveness Cell Rep 2020 31 107731 10.1016/j.celrep.2020.107731 32521256
Berthenet K, Castillo Ferrer C, Fanfone D, Popgeorgiev N, Neves D, Bertolino P, et al. Failed apoptosis enhances melanoma cancer cell aggressiveness. Cell Rep. 2020;31:107731 10.1016/j.celrep.2020.10773132521256 10.1016/j.celrep.2020.107731
147. Pena JC Rudin CM Thompson CB A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas Cancer Res 1998 58 2111 6 9605754
Pena JC, Rudin CM, Thompson CB. A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res. 1998;58:2111–6.9605754
148. Suzuki A Itami S Ohishi M Hamada K Inoue T Komazawa N Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation Cancer Res 2003 63 674 81 12566313
Suzuki A, Itami S, Ohishi M, Hamada K, Inoue T, Komazawa N, et al. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res. 2003;63:674–81.12566313
149. Arnott CH Scott KA Moore RJ Robinson SC Thompson RG Balkwill FR Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development Oncogene 2004 23 1902 10 10.1038/sj.onc.1207317 14661063
Arnott CH, Scott KA, Moore RJ, Robinson SC, Thompson RG, Balkwill FR. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene. 2004;23:1902–10. 10.1038/sj.onc.120731714661063 10.1038/sj.onc.1207317
150. van Hogerlinden M Rozell BL Ahrlund-Richter L Toftgard R Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling Cancer Res 1999 59 3299 303 10416581
van Hogerlinden M, Rozell BL, Ahrlund-Richter L, Toftgard R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 1999;59:3299–303.10416581
151. Dajee M Lazarov M Zhang JY Cai T Green CL Russell AJ NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia Nature 2003 421 639 43 10.1038/nature01283 12571598
Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature. 2003;421:639–43. 10.1038/nature0128312571598 10.1038/nature01283
152. Vredevoogd DW Kuilman T Ligtenberg MA Boshuizen J Stecker KE de Bruijn B Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold Cell 2019 178 585 99.e515 10.1016/j.cell.2019.06.014 31303383
Vredevoogd DW, Kuilman T, Ligtenberg MA, Boshuizen J, Stecker KE, de Bruijn B, et al. Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold. Cell. 2019;178:585–99.e515. 10.1016/j.cell.2019.06.01431303383 10.1016/j.cell.2019.06.014
153. Geserick P Wang J Schilling R Horn S Harris PA Bertin J Absence of RIPK3 predicts necroptosis resistance in malignant melanoma Cell Death Dis 2015 6 e1884 10.1038/cddis.2015.240 26355347
Geserick P, Wang J, Schilling R, Horn S, Harris PA, Bertin J, et al. Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death Dis. 2015;6:e1884 10.1038/cddis.2015.24026355347 10.1038/cddis.2015.240
154. Schmitt CA Wang B Demaria M Senescence and cancer - role and therapeutic opportunities Nat Rev Clin Oncol 2022 19 619 36 10.1038/s41571-022-00668-4 36045302
Schmitt CA, Wang B, Demaria M. Senescence and cancer - role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19:619–36. 10.1038/s41571-022-00668-436045302 10.1038/s41571-022-00668-4
155. Liu J, Zheng R, Zhang Y, Jia S, He Y, Liu J. The cross talk between cellular senescence and melanoma: from molecular pathogenesis to target therapies. Cancers. 2023;15. 10.3390/cancers15092640
156. Li J Huang S Zeng L Li K Yang L Gao S Necroptosis in head and neck squamous cell carcinoma: characterization of clinicopathological relevance and in vitro cell model Cell Death Dis 2020 11 391 10.1038/s41419-020-2538-5 32444644
Li J, Huang S, Zeng L, Li K, Yang L, Gao S, et al. Necroptosis in head and neck squamous cell carcinoma: characterization of clinicopathological relevance and in vitro cell model. Cell Death Dis. 2020;11:391 10.1038/s41419-020-2538-532444644 10.1038/s41419-020-2538-5
157. Oka K Fujioka S Kawamura Y Komohara Y Chujo T Sekiguchi K Resistance to chemical carcinogenesis induction via a dampened inflammatory response in naked mole-rats Commun Biol 2022 5 287 10.1038/s42003-022-03241-y 35354912
Oka K, Fujioka S, Kawamura Y, Komohara Y, Chujo T, Sekiguchi K, et al. Resistance to chemical carcinogenesis induction via a dampened inflammatory response in naked mole-rats. Commun Biol. 2022;5:287 10.1038/s42003-022-03241-y35354912 10.1038/s42003-022-03241-y
158. Hsu YC Pasolli HA Fuchs E Dynamics between stem cells, niche, and progeny in the hair follicle Cell 2011 144 92 105 10.1016/j.cell.2010.11.049 21215372
Hsu YC, Pasolli HA, Fuchs E. Dynamics between stem cells, niche, and progeny in the hair follicle. Cell. 2011;144:92–105. 10.1016/j.cell.2010.11.04921215372 10.1016/j.cell.2010.11.049
